https://www.lmi.no/2025/09/10/flere-diabeteslegemidler-trekkes-fra-markedet/ 2025-09-10T07:43:58+00:00 https://www.lmi.no/2025/09/10/novo-nordisk-kutter-9-000-jobber/ 2025-09-10T07:45:35+00:00 https://www.lmi.no/2025/09/10/novo-nordisk-om-norske-jobbkutt-hvert-land-vil-bli-pavirket-pa-ulikt-vis/ 2025-09-10T07:46:49+00:00 https://www.lmi.no/2025/09/10/medwatch-legemiddelindustrien-ber-ap-sikre-rammevilkar/ 2025-09-10T07:54:16+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Skjermbilde-2025-09-10-094748.png https://www.lmi.no/wp-content/uploads/2025/09/Skjermbilde-2025-09-10-094748.png https://www.lmi.no/2025/09/11/lmi-pa-nordic-pharmaceutical-forums-10-arsjubileum/ 2025-09-11T08:40:24+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Nordic-Pharmaceutical-Forum-2025.jpg https://www.lmi.no/wp-content/uploads/2025/09/Nordic-Pharmaceutical-Forum-2025.jpg https://www.lmi.no/2025/09/11/esmo-presenterer-nok-en-gang-norge-som-studieland-pa-kreft-feltet/ 2025-09-11T13:26:54+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Berlin_AdobeStock-2-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/09/Berlin_AdobeStock-2-scaled.jpeg https://www.lmi.no/2025/09/11/trump-vurderer-forbud-mot-medisin-fra-kina/ 2025-09-11T13:30:44+00:00 https://www.lmi.no/2025/09/11/stor-studie-om-slankemedisin-fant-dramatiske-fordeler-mot-alvorlig-sykdom/ 2025-09-11T13:31:47+00:00 https://www.lmi.no/2025/09/11/novo-nordisk-direktoren-ville-kanskje-ikke-ansatt-sa-mange/ 2025-09-11T13:33:53+00:00 https://www.lmi.no/2025/09/11/grunnleggerne-av-vaccibody-utnevnes-til-riddere-av-st-olavs-orden/ 2025-09-11T13:34:48+00:00 https://www.lmi.no/2025/09/12/debatt-feil-tallgrunnlag-i-helsetjenesten-kan-ogsa-redde-liv/ 2025-09-12T09:50:13+00:00 https://www.lmi.no/2025/09/12/ny-blodtrykksmedisin-med-god-effekt-spennende/ 2025-09-12T09:51:05+00:00 https://www.lmi.no/2025/09/12/giftig-protein-er-nokkelen-til-a-forsta-parkinsons-sykdom-ifolge-forskere/ 2025-09-12T09:51:50+00:00 https://www.lmi.no/2025/09/12/novo-nordisk-mot-laveste-vekst-i-driftsresultat-siden-2020/ 2025-09-12T09:52:32+00:00 https://www.lmi.no/2025/09/12/artbio-klare-for-fase-1-studier-i-usa/ 2025-09-12T09:53:14+00:00 https://www.lmi.no/2025/09/12/msd-tar-en-brexit-skroter-planer-om-storbritannia/ 2025-09-12T09:53:58+00:00 https://www.lmi.no/2025/09/12/eu-lanserer-felles-innsats-for-a-sikre-medisinske-lagre-i-krisesituasjoner/ 2025-09-12T09:54:43+00:00 https://www.lmi.no/2025/09/15/forlater-sanofi-inn-pa-stortinget/ 2025-09-15T10:16:19+00:00 https://www.lmi.no/2025/09/15/blodkreftforeningen-skal-vaere-en-trygg-havn-og-en-tydelig-stemme/ 2025-09-15T10:17:41+00:00 https://www.lmi.no/2025/09/15/star-bak-det-som-kan-bli-norges-neste-legemiddel-pa-markedet-ma-ta-avgjorende-veivalg/ 2025-09-15T10:18:42+00:00 https://www.lmi.no/2025/09/15/homeopati-kan-hindre-antibiotikaresistens-mener-homeopatene/ 2025-09-15T10:20:05+00:00 https://www.lmi.no/2025/09/15/gront-lys-for-utbygging-for-agilera-pharma-jakter-farma-partner/ 2025-09-15T10:21:11+00:00 https://www.lmi.no/2025/09/15/medlemsmote-om-stortingsvalget/ 2025-09-15T10:55:15+00:00 https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/2025/09/15/siop-presenterer-norge-som-studieland-innen-barneonkologi/ 2025-09-15T11:44:16+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Amsterdam_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/06/Amsterdam_AdobeStock-scaled.jpeg https://www.lmi.no/2025/09/16/verdens-helseorganisasjon-stiller-seg-bak-bruk-av-slankesproyter-mot-fedme/ 2025-09-16T08:25:50+00:00 https://www.lmi.no/2025/09/16/musklene-til-torkil-54-forsvinner-gradvis-nektes-behandling/ 2025-09-16T08:26:54+00:00 https://www.lmi.no/2025/09/16/utvider-godkjenningen-av-rybelsus-til-a-omfatte-kardiovaskulaere-fordeler/ 2025-09-16T08:27:49+00:00 https://www.lmi.no/2025/09/16/astra-zeneca-pauser-investering-i-storbritannia/ 2025-09-16T08:28:44+00:00 https://www.lmi.no/2025/09/16/legemiddelgiganter-snur-ryggen-til-storbritannia-mener-nhs-politikk-skremmer-vekk-investeringer/ 2025-09-16T08:29:37+00:00 https://www.lmi.no/2025/08/20/fiskehelseselskapene-markerte-seg-pa-aqua-nor/ 2025-09-16T11:25:34+00:00 https://www.lmi.no/wp-content/uploads/2025/08/MSD-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Stim-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Benchmark-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/MSD-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Pharmaq-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Pharmaqademy-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/ACD-scaled.jpg https://www.lmi.no/2025/09/15/lmi-motte-regjeringen-om-helsekatapult/ 2025-09-16T12:52:05+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Helsekatapult-mote-med-HOD-og-NFD.jpg https://www.lmi.no/wp-content/uploads/2025/09/Helsekatapult-mote-med-HOD-og-NFD.jpg https://www.lmi.no/2025/09/17/ny-slankepille-kan-kutte-vekten-med-en-femtedel/ 2025-09-17T07:54:51+00:00 https://www.lmi.no/2025/09/17/lillys-slankepille-kan-fa-lynrask-fda-godkjenning-kan-gi-milliardinntekter/ 2025-09-17T07:56:02+00:00 https://www.lmi.no/2025/09/17/ogsa-sanofi-fryser-britiske-investeringer/ 2025-09-17T07:56:58+00:00 https://www.lmi.no/2025/09/17/novo-nordisk-rydder-i-jobbtitler/ 2025-09-17T07:58:21+00:00 https://www.lmi.no/2025/09/17/psoriasis-knyttet-til-okt-risiko-for-oyesykdom-som-kan-gi-synstap/ 2025-09-17T07:59:23+00:00 https://www.lmi.no/2025/09/17/kommentar-kliniske-studier-norge-ma-spille-i-den-internasjonale-toppdivisjonen/ 2025-09-17T08:11:58+00:00 https://www.lmi.no/2025/09/17/kronikk-alle-topplederne-er-menn-vi-trenger-strukturelle-grep-i-biotek/ 2025-09-17T08:15:12+00:00 https://www.lmi.no/2025/09/16/medlemsmote-fra-industrien-til-tinget-og-motsatt/ 2025-09-17T12:15:28+00:00 https://www.lmi.no/wp-content/uploads/2025/09/front-valgmote-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/09/front-valgmote-kopi.jpg https://www.lmi.no/2025/09/17/patient-safety-day-legemidler-til-gravide-og-ammende-hva-er-trygt/ 2025-09-17T14:05:39+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Gravid-tar-medisin_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/09/Gravid-tar-medisin_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/09/BMO_Novartis_1.jpg https://www.lmi.no/wp-content/uploads/2025/09/Nina-Malmberg-.png https://www.lmi.no/2025/09/08/nominer-dine-kandidater-til-prisen-for-fremragende-innsats-i-kliniske-studier/ 2025-09-18T12:58:27+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde-scaled.png https://www.lmi.no/2025/09/22/roche-kjoper-amerikansk-biotekselskap-for-over-30-milliarder-kroner/ 2025-09-22T09:43:51+00:00 https://www.lmi.no/2025/09/22/aldring-og-ms-slik-pavirker-sykdommen-eldre-pasienter-og-hva-fremtidens-behandling-kan-bli/ 2025-09-22T09:44:52+00:00 https://www.lmi.no/2025/09/22/hvor-mye-av-vekttapet-med-slankemedisin-er-muskler-liten-studie-har-undersokt-med-mr/ 2025-09-22T09:45:53+00:00 https://www.lmi.no/2025/09/22/studie-av-slankepille-viser-betydelig-vekttap/ 2025-09-22T09:47:14+00:00 https://www.lmi.no/2025/09/22/novo-nordisk-aksjonaerer-onsker-a-bytte-ut-helge-lund-som-styreleder/ 2025-09-22T09:48:03+00:00 https://www.lmi.no/2025/09/22/gsk-varsler-store-investeringer-i-usa/ 2025-09-22T09:49:09+00:00 https://www.lmi.no/2025/09/22/vil-utvide-bruk-mye-mindre-plager/ 2025-09-22T09:50:22+00:00 https://www.lmi.no/2025/09/22/kreftbehandling-og-sjeldne-sykdommer-dominerer-neste-mote-i-beslutningsforum/ 2025-09-22T09:51:16+00:00 https://www.lmi.no/2025/09/22/slik-skal-halden-pharma-fa-ned-det-skyhoye-sykefravaeret/ 2025-09-22T09:53:06+00:00 https://www.lmi.no/2025/09/22/eli-lilly-med-flere-data-for-fedmepille-investor-spar-dodt-lop-med-novo-nordisk-konkurrent/ 2025-09-22T09:53:54+00:00 https://www.lmi.no/2025/09/22/eli-lilly-har-sokt-om-godkjenning-for-mounjaro-til-barn/ 2025-09-22T09:54:50+00:00 https://www.lmi.no/2025/09/22/novo-nordisk-fruergaard-ble-ikke-sparket/ 2025-09-22T09:56:07+00:00 https://www.lmi.no/2025/09/22/dodelig-sopp-sprer-seg-pa-sykehus-en-okende-bekymring/ 2025-09-22T09:56:55+00:00 https://www.lmi.no/2025/09/22/anbefaler-14-nye-legemidler/ 2025-09-22T09:57:39+00:00 https://www.lmi.no/2025/09/22/mandag-kan-nok-en-sproytebasert-immunterapi-bli-innfort-hva-betyr-det-for-pasientene/ 2025-09-22T09:58:51+00:00 https://www.lmi.no/2025/09/22/norsk-forskning-kan-endre-maten-migrene-behandles-pa-i-hele-verden/ 2025-09-22T09:59:49+00:00 https://www.lmi.no/2025/09/22/blodprovetest-kan-apne-doren-til-nye-alzheimer-legemidler-behandles-i-bestillerforum-mandag/ 2025-09-22T10:01:02+00:00 https://www.lmi.no/2025/09/22/pfizer-naermer-seg-oppkjop-av-fedmeselskap/ 2025-09-22T10:01:45+00:00 https://www.lmi.no/2025/09/22/ge-healthcare-vurderer-salg-av-kina-avdeling/ 2025-09-22T10:03:09+00:00 https://www.lmi.no/2025/09/22/lmi-i-altinget-det-er-behov-for-a-rydde-opp-i-alternativkostnaden/ 2025-09-22T10:10:16+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Leif-rune-altinget-tilsvarBarra.png https://www.lmi.no/wp-content/uploads/2025/09/Leif-rune-altinget-tilsvarBarra.png https://www.lmi.no/2025/09/22/innspill-til-dmp-om-alternativkostnad/ 2025-09-22T10:14:59+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Barbara-priomeldingen-2.png https://www.lmi.no/wp-content/uploads/2025/05/Barbara-priomeldingen-2.png https://www.lmi.no/2025/09/23/helseministeren-svarer-om-alternativkostnad/ 2025-09-23T10:02:21+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-26-130819.png https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-26-130819.png https://www.lmi.no/2025/09/23/trump-frarader-gravide-a-bruke-paracetamol-%e2%81%a0-bekymret/ 2025-09-23T10:08:05+00:00 https://www.lmi.no/2025/09/23/beslutningsforum-innforer-immunterapi-injeksjon-og-ni-andre-metoder/ 2025-09-23T14:36:01+00:00 https://www.lmi.no/2025/09/23/bekrefter-subkutan-opdivo-erstatter-intravenos-fra-1-november/ 2025-09-23T14:37:06+00:00 https://www.lmi.no/2025/09/23/roche-satser-stort-pa-fedmelegemiddel-vil-bli-topp-tre-aktor-i-markedet/ 2025-09-23T14:38:00+00:00 https://www.lmi.no/2025/09/23/pfizer-kjoper-fedme-biotek-i-kjempeavtale/ 2025-09-23T14:39:20+00:00 https://www.lmi.no/2025/09/23/bayer-tester-bade-celle-og-genterapi-for-a-bremse-parkinsons-sykdom/ 2025-09-23T14:40:52+00:00 https://www.lmi.no/2025/09/23/46-legemidler-under-metodevurdering-kreft-dominerer/ 2025-09-23T14:41:44+00:00 https://www.lmi.no/2025/09/24/5000-ansatte-skal-ut-na-sparkes-de-fra-novo/ 2025-09-24T11:25:17+00:00 https://www.lmi.no/2025/09/24/autisme-utspill-sendte-farmasiselskap-til-bunns-na-stiger-aksjen/ 2025-09-24T11:26:06+00:00 https://www.lmi.no/2025/09/24/dmp-blokkerer-60-ulovlige-nettsteder-om-legemidler/ 2025-09-24T11:27:06+00:00 https://www.lmi.no/2025/09/24/fda-godkjenner-ny-versjon-av-blockbusteren-keytruda/ 2025-09-24T11:27:44+00:00 https://www.lmi.no/2025/09/24/eus-helsetopp-tilgang-til-legemidler-for-sjeldne-sykdommer-er-et-markedssporsmal/ 2025-09-24T11:28:27+00:00 https://www.lmi.no/2025/09/24/nektet-a-handhilse-ge-healthcare-innforer-hjertehilsen/ 2025-09-24T11:29:31+00:00 https://www.lmi.no/2025/09/24/vil-jobbe-for-a-fa-car-t-og-bite-studier-innen-revmatologi-til-norge/ 2025-09-24T12:55:14+00:00 https://www.lmi.no/wp-content/uploads/2025/09/NorTrials-nettverksmote-om-celleterapi-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/NorTrials-nettverksmote-om-celleterapi-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Revmatologi-og-car-t_Novartis-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Revmatologi-og-car-t_AZ-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Revmatologi-og-car-t_Schjesvold-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Revmatologi-og-car-t_Ingerid-scaled.jpg https://www.lmi.no/2025/09/24/shi-ber-om-innspill-til-ny-legemiddelstrategi/ 2025-09-24T16:12:18+00:00 https://www.lmi.no/wp-content/uploads/2025/09/LMI-hos-SHI.jpg https://www.lmi.no/wp-content/uploads/2025/09/LMI-hos-SHI.jpg https://www.lmi.no/2025/09/25/120-millioner-kroner-til-forskning-og-kommersialisering/ 2025-09-25T06:50:53+00:00 https://www.lmi.no/wp-content/uploads/2022/10/forskning-scaled.jpeg https://www.lmi.no/wp-content/uploads/2016/11/Forskning.jpg https://www.lmi.no/2025/09/25/stensland-og-svendsrud-om-valget-potensielt-mer-makt-i-stortinget/ 2025-09-25T07:07:53+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Medlemsmote-om-stortingsvalget_2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Medlemsmote-om-stortingsvalget_2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Medlemsmote-om-stortingsvalget-2025.jpg https://www.lmi.no/2025/09/25/eli-lilly-sjefen-storbritannia-er-det-verste-landet-i-europa-for-legemiddelpriser/ 2025-09-25T08:54:50+00:00 https://www.lmi.no/2025/09/25/gsk-har-produksjonsproblemer-rasjonering-av-valtrex-og-zovirax/ 2025-09-25T08:56:34+00:00 https://www.lmi.no/2025/09/25/huntingtons-gaten-lost-forskere-med-historisk-gjennombrudd/ 2025-09-25T08:57:42+00:00 https://www.lmi.no/2025/09/25/sentralbanksjef-dansk-okonomi-star-og-faller-ikke-med-novo-nordisk/ 2025-09-25T08:59:24+00:00 https://www.lmi.no/2025/09/25/svensk-alzheimerbehandling-godkjent-i-australia-pa-tredje-forsok/ 2025-09-25T09:00:17+00:00 https://www.lmi.no/2025/09/25/ms-er-en-erfaringssykdom-helene-wangberg-om-a-bli-eldre-med-multippel-sklerose/ 2025-09-25T09:01:08+00:00 https://www.lmi.no/2025/09/25/lillys-jaypirca-viser-sterke-resultater-i-forstelinje-kll/ 2025-09-25T09:02:28+00:00 https://www.lmi.no/2025/09/25/tror-eli-lilly-vinner-kampen-om-fedmepiller/ 2025-09-25T09:03:39+00:00 https://www.lmi.no/2025/09/26/trump-varsler-100-prosent-toll-pa-legemidler/ 2025-09-26T08:52:39+00:00 https://www.lmi.no/2025/09/26/blodprove-som-oppdager-alzheimer-tas-i-bruk-i-norge/ 2025-09-26T08:53:39+00:00 https://www.lmi.no/2025/09/26/eli-lilly-avbryter-muskeltapstudie-etter-under-en-maned/ 2025-09-26T08:54:38+00:00 https://www.lmi.no/2025/09/26/vestre-svarer-troen-lover-rask-utredning-av-terskelverdi-innen-nyttar/ 2025-09-26T09:00:39+00:00 https://www.lmi.no/2025/09/26/bioarctic-sikter-mot-2026-lansering-av-alzheimer-medisin-ma-etablere-en-helt-ny-behandlingsvei/ 2025-09-26T09:01:30+00:00 https://www.lmi.no/2025/09/26/kreftanbudet-endrer-behandlingslandskapet-dette-er-vinnerne-og-de-viktigste-endringene/ 2025-09-26T09:02:23+00:00 https://www.lmi.no/2025/09/26/farmasigiganter-i-japan-og-sor-korea-faller-tungt-etter-trumps-siste-tollsjokk/ 2025-09-26T09:03:24+00:00 https://www.lmi.no/2025/09/26/nightmare-bacteria-oker-i-norge-na-er-fhi-bekymret/ 2025-09-26T09:06:11+00:00 https://www.lmi.no/2025/09/26/eli-lilly-avbryter-muskeltapstudie-etter-under-en-maned-2/ 2025-09-26T09:12:00+00:00 https://www.lmi.no/2025/09/26/felleskatalog-sjefen-ble-arets-farmasoyt/ 2025-09-26T10:22:17+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Bente-Jansen-arets-farmasoyt-sammen-med-leder-i-Farmaceutene-Birgitte-Lloyd-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Bente-Jansen-arets-farmasoyt-sammen-med-leder-i-Farmaceutene-Birgitte-Lloyd-i-scaled.jpg https://www.lmi.no/2025/09/26/slik-jobber-lmi-med-mfn-og-toll/ 2025-09-26T12:10:17+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/09/29/legemiddeltoll-lmi-bekymret-for-ulike-vilkar-mellom-norge-og-eu/ 2025-09-29T10:39:50+00:00 https://www.lmi.no/2025/09/29/trump-innforer-kjempetoll-pa-legemidler-svaert-bekymret/ 2025-09-29T10:40:34+00:00 https://www.lmi.no/2025/09/29/trump-truer-med-100-prosent-toll-pa-legemidler-lmi-advarer-om-konsekvensene/ 2025-09-29T10:41:41+00:00 https://www.lmi.no/2025/09/29/frich-blir-ny-styreleder-i-nortrials/ 2025-09-29T10:42:49+00:00 https://www.lmi.no/2025/09/29/eli-lillys-nye-alzheimer-medisin-har-fatt-eu-godkjenning/ 2025-09-29T10:43:52+00:00 https://www.lmi.no/2025/09/29/legemiddelindustrien-i-europa-fortviler-etter-tolltrussel/ 2025-09-29T10:45:08+00:00 https://www.lmi.no/2025/09/29/historisk-gjennombrudd-gir-hap/ 2025-09-29T10:45:58+00:00 https://www.lmi.no/2025/09/29/kuren-kan-vaere-klar-om-fa-ar/ 2025-09-29T10:46:48+00:00 https://www.lmi.no/2025/09/29/fhi-frykter-spredning-bekymringsfullt/ 2025-09-29T10:47:37+00:00 https://www.lmi.no/2025/09/29/hevder-kroppen-kan-lage-sin-egen-ozempic/ 2025-09-29T10:48:26+00:00 https://www.lmi.no/2025/09/29/lmi-i-e24-trump-innforer-kjempetoll-pa-legemidler-svaert-bekymret/ 2025-09-29T10:56:19+00:00 https://www.lmi.no/wp-content/uploads/2025/09/e24-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/09/e24-kopi.jpg https://www.lmi.no/2025/09/30/lmi-deltok-pa-hastemote-om-toll-hos-nfd/ 2025-09-30T09:18:58+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Naeringsdepartementet.png https://www.lmi.no/wp-content/uploads/2025/09/Naeringsdepartementet.png https://www.lmi.no/2025/09/30/lmi-frykter-amerikanske-tollsatser/ 2025-09-30T09:28:42+00:00 https://www.lmi.no/2025/09/30/slutter-i-novo-nordisk-norge/ 2025-09-30T09:29:58+00:00 https://www.lmi.no/2025/09/30/stor-skandinavisk-studie-vanlig-reseptfritt-legemiddel-kan-kanskje-bli-et-vapen-mot-kreft/ 2025-09-30T09:31:19+00:00 https://www.lmi.no/2025/09/30/astra-zeneca-florter-med-new-york-kan-forlate-london/ 2025-09-30T09:32:12+00:00 https://www.lmi.no/2025/09/30/gsks-toppsjef-slutter/ 2025-09-30T09:34:56+00:00 https://www.lmi.no/2025/09/30/eu-har-godkjent-kisunla-na-starter-norsk-vurdering-av-alzheimers-medisinen/ 2025-09-30T09:36:48+00:00 https://www.lmi.no/2025/09/30/trumps-legemiddeltoll-gjelder-ikke-land-med-handelsavtale/ 2025-09-30T09:37:31+00:00 https://www.lmi.no/2025/09/30/meld-deg-pa-lov-og-bransjekurs/ 2025-09-30T10:04:22+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Deltagerne-Lov-og-bransje.jpeg https://www.lmi.no/2025/10/01/direktoratet-stanset-ulovlige-nettsteder-for-reklamebrudd/ 2025-10-01T09:15:29+00:00 https://www.lmi.no/2025/10/01/ny-kreftmedisin-far-samme-pris-som-i-usa/ 2025-10-01T09:16:15+00:00 https://www.lmi.no/2025/10/01/dmp-besokte-medicinradet-i-danmark/ 2025-10-01T09:17:07+00:00 https://www.lmi.no/2025/10/01/pfizer-hopper-pa-bors-etter-trump-avtale/ 2025-10-01T09:18:18+00:00 https://www.lmi.no/2025/10/01/hod-omgjor-vedtak-novartis-frikjent-for-ulovlig-legemiddelreklame/ 2025-10-01T09:19:16+00:00 https://www.lmi.no/2025/10/01/legemiddelkjempene-kutter-i-jobber-industrien-gar-inn-i-en-av-sine-hardeste-sykluser-pa-flere-tiar/ 2025-10-01T09:20:01+00:00 https://www.lmi.no/2025/10/01/ny-norsk-studie-skal-teste-funksjonell-presisjonsmedisin-for-tarmkreft-med-spredning/ 2025-10-01T09:20:45+00:00 https://www.lmi.no/2025/10/01/status-for-lmis-strategiarbeid-2/ 2025-10-01T10:03:39+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/2025/10/01/dmp-inviterer-lmis-medlemmer-til-dialogmoter/ 2025-10-01T11:51:50+00:00 https://www.lmi.no/wp-content/uploads/2025/01/Trygve-Ottersen-bredde-550x412-1.jpg https://www.lmi.no/wp-content/uploads/2025/03/Trygve-Ottersen.jpg https://www.lmi.no/2025/10/02/ny-tablett-mot-kronisk-elveblest-godkjent-i-usa/ 2025-10-02T09:29:32+00:00 https://www.lmi.no/2025/10/02/barneleger-krever-vaksinering-mot-rs-virus/ 2025-10-02T09:30:44+00:00 https://www.lmi.no/2025/10/02/farma-norge-mener-trumps-legemiddeltoll-kan-svekke-investeringene-i-generika/ 2025-10-02T09:31:25+00:00 https://www.lmi.no/2025/10/02/naeringsministeren-vet-ikke-om-norge-rammes-av-ny-legemiddeltoll/ 2025-10-02T09:32:10+00:00 https://www.lmi.no/2025/10/02/kritisk-til-helseforetakenes-pengebruk-henger-ikke-pa-greip/ 2025-10-02T09:33:26+00:00 https://www.lmi.no/2025/10/02/lmi-har-levert-skriftlig-innspill-til-shi/ 2025-10-02T13:55:26+00:00 https://www.lmi.no/wp-content/uploads/2025/10/IMG_8438-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/IMG_8438-scaled.jpg https://www.lmi.no/2025/10/03/frustrert-av-ny-nesespray-%e2%81%a0-renner-ut/ 2025-10-03T07:42:26+00:00 https://www.lmi.no/2025/10/03/thermo-fisher-flytter-inn-hos-astra-zeneca-i-goteborg/ 2025-10-03T07:43:22+00:00 https://www.lmi.no/2025/10/03/vil-oke-antallet-kliniske-studier-og-korte-ned-tiden-til-rekruttering-av-pasienter/ 2025-10-03T07:44:38+00:00 https://www.lmi.no/2025/10/03/nye-europeiske-retningslinjer-wegovy-og-mounjaro-skal-vaere-forstevalg-ved-fedmebehandling/ 2025-10-03T07:45:38+00:00 https://www.lmi.no/2025/10/03/fda-stanser-mottak-av-nye-soknader-om-legemidler-og-medisinsk-utstyr/ 2025-10-03T07:46:46+00:00 https://www.lmi.no/2025/10/03/vi-ma-vaere-brannforebyggere-ikke-bare-brannslukkere-astmaekspert-om-viktigheten-av-tidlig-intervensjon/ 2025-10-03T07:49:00+00:00 https://www.lmi.no/2025/10/03/slik-kjemper-eisai-og-eli-lilly-om-a-bli-forst-pa-det-norske-alzheimer-markedet/ 2025-10-03T07:50:06+00:00 https://www.lmi.no/2025/10/03/trump-setter-legemiddeltoll-pa-vent-fortsatt-uklart-om-norge-rammes/ 2025-10-03T07:51:03+00:00 https://www.lmi.no/2025/10/03/ny-alzheimer-behandling-far-hurtigspor-status/ 2025-10-03T07:52:16+00:00 https://www.lmi.no/2025/10/06/debatt-uten-helse-som-drivkraft-mister-norge-fart/ 2025-10-06T09:32:11+00:00 https://www.lmi.no/2025/10/06/forskere-vil-finne-ut-om-virus-star-bak-sykdommer-i-hjernen/ 2025-10-06T09:33:00+00:00 https://www.lmi.no/2025/10/06/er-helseforetakenes-tid-over/ 2025-10-06T09:33:57+00:00 https://www.lmi.no/2025/10/06/hvordan-vil-ola-nordmann-fordele-helsekronene-vare/ 2025-10-06T09:34:57+00:00 https://www.lmi.no/2025/10/06/astra-zenecas-sjelden-sjef-a-teste-og-feile-teste-og-feile-er-ekstremt-ressurskrevende/ 2025-10-06T09:36:00+00:00 https://www.lmi.no/2025/10/06/biotek-grunder-flyttet-til-sveits-skatt-var-ikke-driveren/ 2025-10-06T09:36:44+00:00 https://www.lmi.no/2025/10/06/finnes-det-en-beredskapsplan-for-legemidler/ 2025-10-06T09:39:32+00:00 https://www.lmi.no/2025/10/06/dodsdomte-kjartan-ser-en-mulighet-til-a-redde-livet-men-staten-gir-ham-ikke-lov/ 2025-10-06T09:40:27+00:00 https://www.lmi.no/2025/10/06/ny-genterapi-viser-lovende-resultater-for-huntingtons-sykdom/ 2025-10-06T09:46:05+00:00 https://www.lmi.no/2025/10/06/blareseptanbud-vinner-med-gode-studieresultater/ 2025-10-06T09:47:56+00:00 https://www.lmi.no/2025/10/06/norges-svake-vaksinesatsing-svekker-samfunnsberedskapen/ 2025-10-06T09:49:21+00:00 https://www.lmi.no/2025/10/06/norske-spedbarn-sist-ute-hvorfor-er-ikke-rs-virus-beskyttelse-innfort-i-norge/ 2025-10-06T09:50:39+00:00 https://www.lmi.no/2025/10/06/na-kommer-smellen-betydelig/ 2025-10-06T09:51:26+00:00 https://www.lmi.no/2025/10/07/erik-er-den-eneste-som-fikk-fortsette-pa-medisinen-de-andre-er-dode/ 2025-10-07T09:26:33+00:00 https://www.lmi.no/2025/10/07/fastlege-sluttet-etter-15-ar-%e2%81%a0-vi-moter-kroniske-smertepasienter-pa-en-darlig-mate/ 2025-10-07T09:29:04+00:00 https://www.lmi.no/2025/10/07/studie-apner-for-klimavennlige-inhalatorer/ 2025-10-07T09:30:16+00:00 https://www.lmi.no/2025/10/07/etter-pfizer-avtale-ogsa-gsk-i-dialog-med-trump-om-legemiddelpriser/ 2025-10-07T09:32:29+00:00 https://www.lmi.no/2025/10/07/overtegnet-emisjon-sikrer-navamedic-130-millioner-kroner/ 2025-10-07T09:33:16+00:00 https://www.lmi.no/2025/10/07/rwe-studie-pa-uegw-rinvoq-gir-rask-effekt-ved-ulceros-kolitt/ 2025-10-07T09:34:11+00:00 https://www.lmi.no/2025/10/08/krfs-nestleder-inn-i-helse-og-omsorgskomiteen/ 2025-10-08T08:36:50+00:00 https://www.lmi.no/2025/10/08/vestre-erkjenner-fiasko-for-kliniske-studier-lover-forbedring/ 2025-10-08T08:37:50+00:00 https://www.lmi.no/2025/10/08/nye-uegw-data-pa-rinvoq-kan-pavirke-debatten-om-jak-hemmere/ 2025-10-08T08:38:45+00:00 https://www.lmi.no/2025/10/08/naeringsministeren-om-tollavtale-vanskelig-a-si-hvor-lang-tid-det-vil-ta/ 2025-10-08T08:40:24+00:00 https://www.lmi.no/2025/10/08/fersk-studie-ny-slankepille-gir-betydelig-vekttap/ 2025-10-08T08:42:25+00:00 https://www.lmi.no/2025/10/08/astra-zeneca-storsatser-pa-genredigering-og-ki-for-legemiddelutvikling/ 2025-10-08T08:43:18+00:00 https://www.lmi.no/2025/10/08/ny-jobb-for-tidligere-novo-sjef/ 2025-10-08T08:44:43+00:00 https://www.lmi.no/2025/10/08/debatt-kan-okt-terskelverdi-gi-helsetap/ 2025-10-08T08:47:22+00:00 https://www.lmi.no/2025/10/08/oncoinvents-kreftmedisin-med-oppmuntrende-langtidsdata/ 2025-10-08T09:22:09+00:00 https://www.lmi.no/2025/10/08/nyt-tette-band-mellom-novo-nordisk-og-amerikansk-etikkpanel-vekker-reaksjoner/ 2025-10-08T09:22:53+00:00 https://www.lmi.no/2025/10/08/godt-orientert-om-mfn/ 2025-10-08T09:30:47+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Thomassen_Haswell-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Thomassen_Haswell-scaled.jpg https://www.lmi.no/2025/10/09/erik-er-den-eneste-som-fikk-fortsette-pa-medisinen-de-andre-er-dode-2/ 2025-10-09T10:21:54+00:00 https://www.lmi.no/2025/10/09/tidligere-fda-topp-gar-til-eli-lilly/ 2025-10-09T10:22:54+00:00 https://www.lmi.no/2025/10/09/kom-med-nye-lovforslag-finnes-ingen-norsk-beredskap-uten-europeisk-beredskap/ 2025-10-09T10:26:56+00:00 https://www.lmi.no/2025/10/09/forslag-til-ny-smittevernlov-og-ny-helseberedskapslov-barns-beste-skal-veie-tungt/ 2025-10-09T10:31:57+00:00 https://www.lmi.no/2025/10/09/norsk-beredskap-trenger-naeringslivet/ 2025-10-09T10:35:05+00:00 https://www.lmi.no/2025/10/10/flertallspress-pa-myndighetene-vil-ha-oppdatert-terskelverdi-na/ 2025-10-10T08:53:43+00:00 https://www.lmi.no/2025/10/10/novo-nordisk-kjoper-biotekselskap-for-46-milliarder-kroner-midt-i-oppsigelsesrunde/ 2025-10-10T08:54:36+00:00 https://www.lmi.no/2025/10/10/sanofi-med-lovende-resultater-norsk-selskap-folger-samme-spor/ 2025-10-10T08:55:31+00:00 https://www.lmi.no/2025/10/10/sylvi-listhaug-om-dodsdomte-kjartan-hjerteskjaerende/ 2025-10-10T08:56:38+00:00 https://www.lmi.no/2025/10/10/zelluna-far-gront-lys-for-a-teste-norskutviklet-kreftbehandling-i-storbritannia/ 2025-10-10T08:57:28+00:00 https://www.lmi.no/2025/10/10/novo-nordisk-hemmeligholder-norske-jobbkutt/ 2025-10-10T08:58:33+00:00 https://www.lmi.no/2025/10/10/hovland-ny-leder-i-novo-nordisk-norge/ 2025-10-10T09:06:33+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Nina-Therese-Hovland-foto-Lasse-Moe-Novo-Nordisk-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Nina-Therese-Hovland-foto-Lasse-Moe-Novo-Nordisk-4-scaled.jpg https://www.lmi.no/2025/10/10/novo-nordisk-har-fatt-ny-leder-i-norge/ 2025-10-10T10:31:09+00:00 https://www.lmi.no/2025/10/10/departementsraden-vi-skal-vaere-klare-til-a-jobbe-umiddelbart-ved-rapport-overlevering/ 2025-10-10T10:32:07+00:00 https://www.lmi.no/2025/10/10/slik-er-den-nye-komitefordelingen-pa-stortinget/ 2025-10-10T10:37:15+00:00 https://www.lmi.no/wp-content/uploads/2024/12/48973585938_88eb09a699_o-edited-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/12/48973585938_88eb09a699_o-edited-scaled.jpg https://www.lmi.no/2025/10/13/astra-zeneca-gjor-sin-storste-investering-noensinne/ 2025-10-13T09:22:53+00:00 https://www.lmi.no/2025/10/13/disse-vaksinene-er-viktige-i-krisesituasjoner/ 2025-10-13T09:23:54+00:00 https://www.lmi.no/2025/10/13/nevrolog-advarer-frykter-at-norge-ikke-tar-migrene-pa-alvor/ 2025-10-13T09:29:25+00:00 https://www.lmi.no/2025/10/13/102-fodende-har-sluppet-unodvendig-antibiotika/ 2025-10-13T09:30:09+00:00 https://www.lmi.no/2025/10/13/bekrefter-farlig-bivirkning/ 2025-10-13T09:30:59+00:00 https://www.lmi.no/2025/10/13/astra-zeneca-har-inngatt-avtale-om-lavere-legemiddelpriser/ 2025-10-13T09:31:47+00:00 https://www.lmi.no/2025/10/13/cialis-blir-reseptfritt-det-er-flere-ting-som-en-fastlege-kunne-hjulpet-mye-med/ 2025-10-13T09:32:52+00:00 https://www.lmi.no/2025/10/13/novo-nordisk-legger-ned-celleterapi-program/ 2025-10-13T09:33:36+00:00 https://www.lmi.no/2025/10/13/vil-bygge-katapult-for-radiofarmasi-trenger-20-millioner-kroner/ 2025-10-13T09:34:58+00:00 https://www.lmi.no/2025/10/13/rundebordskonferanse-pa-radhuset/ 2025-10-13T12:02:37+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Roche-Life-Science-Roundtable-5-front-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Roche-Life-Science-Roundtable-9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/10/Roche-Life-Science-Roundtable-5-scaled.jpeg https://www.lmi.no/2025/10/14/stort-skymoen-intervju-i-healthtalk/ 2025-10-14T09:04:09+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Skymoen-intervju-HT-141025.png https://www.lmi.no/wp-content/uploads/2025/10/Skymoen-intervju-HT-141025.png https://www.lmi.no/2025/10/14/landslagsprofil-rammet-av-alvorlig-sykdom-begynte-a-kaste-opp-blod/ 2025-10-14T09:16:25+00:00 https://www.lmi.no/2025/10/14/norsk-kreftstudie-%e2%81%a0-dette-er-absolutt-et-gjennombrudd/ 2025-10-14T09:17:17+00:00 https://www.lmi.no/2025/10/14/subkutan-keytruda-kan-tas-i-bruk-i-desember-2025-kortere-behandlingstid-men-samme-pris/ 2025-10-14T09:18:12+00:00 https://www.lmi.no/2025/10/14/hoyre-krever-rs-svar-fra-vestre/ 2025-10-14T09:20:07+00:00 https://www.lmi.no/2025/10/14/norsk-livsvitenskap-bransje-har-inntatt-goteborg/ 2025-10-14T09:21:20+00:00 https://www.lmi.no/2025/10/15/statsbudsjettet-2026-nortrials-viderefores-som-i-dag/ 2025-10-15T09:36:28+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Signe-og-ina.png https://www.lmi.no/wp-content/uploads/2025/10/Signe-og-ina.png https://www.lmi.no/wp-content/uploads/2025/10/Vandrehallen-statsbudsjett-2026_LR-og-Bekeng-scaled.jpeg https://www.lmi.no/2025/10/15/statsbudsjettet-2026-urovekkende-at-voksenvaksinasjonsprogrammet-ikke-utvides/ 2025-10-15T09:48:46+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Anne-Margrethe-Hausken-Nordberg-6025-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Anne-Margrethe-Hausken-Nordberg-6025-scaled.jpg https://www.lmi.no/2025/10/15/statsbudsjettet-2026-regjeringen-svikter-egen-helseindustrisatsing/ 2025-10-15T10:03:25+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Naeringsminister-og-Skymoen_Statsbudsjettet2026-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Naeringsminister-og-Skymoen_Statsbudsjettet2026-scaled.jpg https://www.lmi.no/2025/10/15/statsbudsjettet-2026-oppdragene-om-terskelverdien-omtalt/ 2025-10-15T10:32:51+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Barbara-Suter_statsbudsjettet2026.jpg https://www.lmi.no/wp-content/uploads/2025/10/Barbara-Suter_crop_statsbudsjettet2026.jpg https://www.lmi.no/2025/10/15/jeg-kan-ikke-la-mannen-min-do-jeg-vil-kjempe-for-han/ 2025-10-15T11:09:22+00:00 https://www.lmi.no/2025/10/15/sanofi-skuffet-men-ikke-overrasket-over-rsv-avgjorelse/ 2025-10-15T11:10:34+00:00 https://www.lmi.no/2025/10/15/reaksjoner-pa-statsbudsjettet-2026-ikke-pasientenes-budsjett/ 2025-10-15T11:11:43+00:00 https://www.lmi.no/2025/10/15/lmi-hardt-ut-mot-budsjettforslaget-mener-norge-risikerer-risikerer-a-havne-i-lavpris-felle/ 2025-10-15T11:13:11+00:00 https://www.lmi.no/2025/10/15/statsbudsjettet-2026-her-er-de-viktigste-hovedpunktene/ 2025-10-15T11:26:28+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Vandrehallen-statsbudsjett-2026_Vestre-2-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/10/Vandrehallen-statsbudsjett-2026_Vestre-2-scaled.jpeg https://www.lmi.no/2025/10/15/katapult-ordningen-utvides-ikke-radiofarmasi-planer-satt-pa-vent/ 2025-10-15T11:42:07+00:00 https://www.lmi.no/2025/10/15/statsbudsjettet-2026-frykter-svekket-helsetjeneste-og-tapt-konkurransekraft/ 2025-10-15T13:38:19+00:00 https://www.lmi.no/wp-content/uploads/2025/10/nytt-LR-head-statsbudsjett.jpg https://www.lmi.no/wp-content/uploads/2025/10/Leif-Rune-Skymoen_crop_statsbudsjettet2026.jpg https://www.lmi.no/wp-content/uploads/2025/10/Helseminsiter-Vestre-og-Skymoen_statsbudsjettet2026-scaled.jpg https://www.lmi.no/2025/10/16/promoterte-norge-under-nls-days/ 2025-10-16T07:09:34+00:00 https://www.lmi.no/wp-content/uploads/2025/10/fRONT1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Innsider-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0929-scaled.jpg https://www.lmi.no/2025/10/16/norge-trenger-legemiddelproduksjon-men-ikke-i-et-statlig-selskap/ 2025-10-16T09:26:10+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Innlegg-Aftenposten.png https://www.lmi.no/wp-content/uploads/2025/10/Innlegg-Aftenposten.png https://www.lmi.no/2025/10/16/pfizer-toppsjefen-mener-industrien-ma-samarbeide-mer-med-kina/ 2025-10-16T09:43:14+00:00 https://www.lmi.no/2025/10/16/feil-om-retten-til-nodvendige-helsetjenester/ 2025-10-16T09:45:56+00:00 https://www.lmi.no/2025/10/16/lmi-frykter-svekket-helsetjeneste-og-tapt-konkurransekraft/ 2025-10-16T09:48:09+00:00 https://www.lmi.no/2025/10/19/farma-norge-etterlyser-mer-fremoverlent-beredskapspolitikk/ 2025-10-19T17:27:15+00:00 https://www.lmi.no/2025/10/19/brystkreft-biotek-far-millionstotte-av-forskningsradet/ 2025-10-19T17:28:11+00:00 https://www.lmi.no/2025/10/19/dmp-foreslar-at-ketamin-oppfores-pa-narkotikalisten/ 2025-10-19T17:29:09+00:00 https://www.lmi.no/2025/10/19/hoyre-ber-vestre-svare-om-forebygging-av-rs-virus-norge-henger-bakpa/ 2025-10-19T17:30:12+00:00 https://www.lmi.no/2025/10/19/esmo-2025-de-viktigste-studiene-og-norsk-rekord/ 2025-10-19T17:31:00+00:00 https://www.lmi.no/2025/10/19/merck-inngar-avtale-med-trump-om-lavere-priser/ 2025-10-19T17:32:26+00:00 https://www.lmi.no/2025/10/19/babypudder-saken-til-johnson-johnson-nar-europa-saksokes-i-storbritannia/ 2025-10-19T17:33:24+00:00 https://www.lmi.no/2025/10/19/to-nye-legemidler-anbefalt-godkjent-i-europa/ 2025-10-19T17:34:09+00:00 https://www.lmi.no/2025/10/19/softox-solutions-med-eu-stottet-studie-pa-biologiske-krigforingstrusler/ 2025-10-19T17:35:36+00:00 https://www.lmi.no/2025/10/19/enhertu-kan-endre-behandlingsforlopet-ved-tidlig-her2-positiv-brystkreft/ 2025-10-19T17:36:23+00:00 https://www.lmi.no/2025/10/19/et-gjennombrudd-som-vil-endre-behandlingsstandarden-ved-blaerekreft/ 2025-10-19T17:37:11+00:00 https://www.lmi.no/2025/10/19/giredestrant-kan-bli-et-nytt-effektivt-alternativ-etter-cdk4-6-behandling/ 2025-10-19T17:37:57+00:00 https://www.lmi.no/2025/10/19/lavere-dose-cellegift-ga-prostatakreft-pasienter-langt-faerre-alvorlige-bivirkninger-kan-bli-ny-standard/ 2025-10-19T17:39:20+00:00 https://www.lmi.no/2025/10/20/norsk-kreftprosjekt-nytt-hap-for-4-av-10-oppgitte-pasienter/ 2025-10-20T10:39:46+00:00 https://www.lmi.no/2025/10/20/lungekreft-bisepesifikt-antistoff-ga-nesten-dobbelt-sa-lang-tid-uten-tilbakefall-som-immunterapi/ 2025-10-20T10:40:28+00:00 https://www.lmi.no/2025/10/20/usa-godkjenner-novo-nordisks-rybelsus-for-a-redusere-hjerte-og-karrisiko/ 2025-10-20T10:41:21+00:00 https://www.lmi.no/2025/10/20/astra-zeneca-tok-imot-norsk-delegasjon-i-goteborg/ 2025-10-20T13:34:37+00:00 https://www.lmi.no/wp-content/uploads/2025/10/IMG_0947-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0932-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0939-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0947-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0965-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0966-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0978-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/IMG_0990-scaled.jpeg https://www.lmi.no/2025/10/21/gsk-tilbakeviser-rootwelt-maksprisen-var-ikke-del-av-forhandlingene/ 2025-10-21T07:58:34+00:00 https://www.lmi.no/2025/10/21/godkjende-ny-medisin-for-sjeldan-sjukdom-det-kjennest-som-eg-kan-puste-igjen/ 2025-10-21T08:00:11+00:00 https://www.lmi.no/2025/10/21/sma-medisin-innfort-etter-fem-ar-roche-ut-mot-treg-prosess/ 2025-10-21T08:01:20+00:00 https://www.lmi.no/2025/10/21/seks-metoder-fikk-ja-i-beslutningsforum/ 2025-10-21T08:02:13+00:00 https://www.lmi.no/2025/10/21/gront-lys-for-ny-behandling/ 2025-10-21T08:02:57+00:00 https://www.lmi.no/2025/10/21/kinesisk-adc-og-immunterapi-doblet-overlevelsen-til-pasienter-med-her2-positiv-urinveiskreft-positiv-overraskelse/ 2025-10-21T08:03:47+00:00 https://www.lmi.no/2025/10/21/astra-zeneca-lofter-enhertu-som-mulig-ny-standardbehandling-etter-studieresultater/ 2025-10-21T08:04:34+00:00 https://www.lmi.no/2025/10/21/kreftforsker-trodelvy-gir-historisk-forbedring-i-behandling-av-metastatisk-trippel-negativ-brystkreft/ 2025-10-21T08:05:28+00:00 https://www.lmi.no/2025/10/07/norge-i-en-ny-global-konkurransesituasjon-hvordan-sikre-eksportvekst-og-verdiskaping/ 2025-10-21T08:34:35+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Frokostmote_eksport_verdiskaping-1080x1920-1.jpg https://www.lmi.no/wp-content/uploads/2025/10/Frokostmote_eksport_verdiskaping-1080x1920-1.jpg https://www.lmi.no/2025/10/20/fremsnakket-norge-og-norden-under-esmo-i-berlin/ 2025-10-21T11:51:55+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Paneldiskusjon-berlin.png https://www.lmi.no/wp-content/uploads/2025/10/Paneldiskusjon-2-berlin.png https://www.lmi.no/wp-content/uploads/2025/10/fire-place-chat-berlin-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/matchmaking-berlin-scaled.jpg https://www.lmi.no/2025/10/21/lmi-til-naeringskomiteen-norge-taper-kampen-om-investeringene/ 2025-10-21T12:59:15+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Horing_Naeringskomiteen_Leif-Rune.png https://www.lmi.no/wp-content/uploads/2025/10/Horing_Naeringskomiteen_Leif-Rune.png https://www.lmi.no/2025/10/22/kronikk-kunnskapsberedskap-ma-vaere-en-del-av-totalberedskapen/ 2025-10-22T08:51:09+00:00 https://www.lmi.no/2025/10/22/flertallet-i-novo-nordisk-styret-gar-av-etter-uenighet-med-eierfondet/ 2025-10-22T08:52:23+00:00 https://www.lmi.no/2025/10/22/sa-nei-til-kreftmedisin-som-for-har-fatt-ja/ 2025-10-22T08:53:45+00:00 https://www.lmi.no/2025/10/22/gsk-tilbakeviser-rootwelt-maksprisen-var-ikke-del-av-forhandlingene-2/ 2025-10-22T08:54:54+00:00 https://www.lmi.no/2025/10/22/rootwelt-gsk-gikk-inn-i-forhandlingene-med-en-uvanlig-hoy-prisforventning/ 2025-10-22T08:56:01+00:00 https://www.lmi.no/2025/10/22/debatt-unyansert-om-prioritering/ 2025-10-22T08:57:59+00:00 https://www.lmi.no/2025/10/22/debatt-prioriteringens-dilemmaer/ 2025-10-22T08:59:09+00:00 https://www.lmi.no/2025/10/22/debatt-beslutningsforum-har-rettslig-grunnlag-for-a-si-nei/ 2025-10-22T09:01:12+00:00 https://www.lmi.no/2025/10/22/debatt-hvorfor-ma-det-norske-systemet-for-nye-metoder-endres/ 2025-10-22T09:02:30+00:00 https://www.lmi.no/2025/10/22/hemmeligholdt-norske-jobbkutt-na-ma-novo-nordisk-svare/ 2025-10-22T09:03:29+00:00 https://www.lmi.no/2025/10/22/imfinzi-og-bcg-immunterapi-ga-faerre-tilbakefall-for-hoyrisiko-blaerekreft-pasienter-lovende/ 2025-10-22T09:04:59+00:00 https://www.lmi.no/2025/10/22/debatt-systemet-svikter-pasientene/ 2025-10-22T09:06:10+00:00 https://www.lmi.no/2025/10/22/lmi-i-dagens-medisin-systemet-svikter-pasientene/ 2025-10-22T09:10:35+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Systemet-svikter-pasientene_DM.jpg https://www.lmi.no/wp-content/uploads/2025/10/Systemet-svikter-pasientene_DM.jpg https://www.lmi.no/2025/10/22/drug-safety-forum-2025/ 2025-10-22T13:19:56+00:00 https://www.lmi.no/wp-content/uploads/2024/10/AdobeStock_konferansesal-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/10/AdobeStock_konferansesal-scaled.jpeg https://www.lmi.no/2025/10/23/lmi-til-helsekomiteen-lav-betalingsvilje-og-en-nei-kultur-til-ny-innovasjon-gjor-at-pasienter-far-darligere-tilgang/ 2025-10-23T08:05:26+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Horing_Helse_Leif_Rune2.png https://www.lmi.no/wp-content/uploads/2025/10/Horing_Helse_Leif_Rune2.png https://www.lmi.no/2025/10/23/etterlyser-master-hjelp-fra-radiofarmasinaeringen/ 2025-10-23T08:21:54+00:00 https://www.lmi.no/2025/10/23/engelsk-blir-tillatt-pa-nordiske-legemiddelpakninger/ 2025-10-23T08:23:06+00:00 https://www.lmi.no/2025/10/23/debatt-nei-mine-innlegg-handler-ikke-om-den-vanskelige-prioriteringsdiskusjonen-i-klinikken/ 2025-10-23T08:24:37+00:00 https://www.lmi.no/2025/10/23/kaller-masseoppsigelsene-i-novo-nordisk-en-fiasko/ 2025-10-23T08:25:20+00:00 https://www.lmi.no/2025/10/24/nordisk-pilot-kan-bedre-forsyningssikkerheten-for-legemidler/ 2025-10-24T06:49:58+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Regulatorisk-hostmote-2025_panelsamtale-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/06/pakningsvedlegg-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Regulatorisk-hostmote-2025_panelsamtale-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Regulatorisk-hosmote-2025_salen-forfra-1-scaled.jpg https://www.lmi.no/2025/10/24/digitalt-medlemsmote-om-mfn/ 2025-10-24T07:54:22+00:00 https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/2025/10/24/kun-en-igjen-i-ledelsen-i-pci-biotech/ 2025-10-24T08:56:26+00:00 https://www.lmi.no/2025/10/24/herpesmedisin-tilbake-etter-produksjonstrobbel-hos-gsk/ 2025-10-24T08:57:13+00:00 https://www.lmi.no/2025/10/24/eu-pharma-legislation-hva-na/ 2025-10-24T08:57:53+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Regulatorisk-hostmote-2025_SvenningsenOttersenTellnerJansen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Regulatorisk-hostmote-2025_SvenningsenOttersenTellnerJansen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Per-Tellner_Regulatorisk-hostmote-2025-scaled.jpg https://www.lmi.no/2025/10/24/lone-24-har-uhelbredelig-kreft-min-skjebne-er-ikke-satt/ 2025-10-24T08:58:10+00:00 https://www.lmi.no/2025/10/24/gjennombrudd-for-ctdna-veiledet-behandling-ved-blaerekreft-veldig-viktig-studie/ 2025-10-24T08:58:57+00:00 https://www.lmi.no/2025/10/24/ogsa-ansatte-i-novo-nordisk-i-sverige-skjermes/ 2025-10-24T08:59:37+00:00 https://www.lmi.no/2025/10/24/debatt-beslutningsforum-og-rett-til-individuell-vurdering-og-forsvarlige-helsetjenester/ 2025-10-24T09:00:50+00:00 https://www.lmi.no/2025/10/27/industritopp-trump-legger-press-pa-europas-legemiddelindustri/ 2025-10-27T11:34:55+00:00 https://www.lmi.no/2025/10/27/debatt-leo-5-far-ikke-medisinen-han-trenger/ 2025-10-27T11:35:55+00:00 https://www.lmi.no/2025/10/27/bestillerforum-sender-nye-kreft-og-sjeldenlegemidler-videre/ 2025-10-27T11:36:39+00:00 https://www.lmi.no/2025/10/27/helseforetaket-ma-spare-pengar-tillitsvald-fryktar-for-jobbane-til-folk/ 2025-10-27T11:37:29+00:00 https://www.lmi.no/2025/10/27/gsk-etter-nei-til-blenrep-vi-har-forholdt-oss-til-prosessen/ 2025-10-27T11:38:14+00:00 https://www.lmi.no/2025/10/27/fedmebiotek-stanser-utvikling-etter-skuffende-resultater/ 2025-10-27T11:38:59+00:00 https://www.lmi.no/2025/10/27/hvem-har-rett-ord-mot-ord-om-prisen-pa-kreftmedisin/ 2025-10-27T11:39:47+00:00 https://www.lmi.no/2025/10/27/sanofi-overgar-forventningene-etter-rekordsalg-av-storselger/ 2025-10-27T11:40:31+00:00 https://www.lmi.no/2025/10/27/ny-slankestudie-en-tydelig-vinner/ 2025-10-27T11:41:13+00:00 https://www.lmi.no/2025/10/27/novartis-kjoper-rna-selskap-for-12-milliarder-dollar/ 2025-10-27T11:42:04+00:00 https://www.lmi.no/2025/10/27/kun-byrakrater-og-okonomer-skal-radgi-dmp-om-terskelverdi-ingen-leger-pasienter-eller-industri/ 2025-10-27T11:42:50+00:00 https://www.lmi.no/2025/10/28/presentasjoner-fra-regulatorisk-hostmote-2025/ 2025-10-28T10:13:39+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Per-Tellner_Regulatorisk-hostmote-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/Per-Tellner_Regulatorisk-hostmote-2025-scaled.jpg https://www.lmi.no/2025/10/28/ekspertgruppe-om-samfunnsperspektiv-og-personell/ 2025-10-28T11:02:04+00:00 https://www.lmi.no/wp-content/uploads/2017/07/utvalgillustrasjon.jpg https://www.lmi.no/wp-content/uploads/2025/10/Utvalg-scaled.jpg https://www.lmi.no/2025/10/28/frykter-a-havne-i-rullestol-jeg-kan-ikke-bare-vente-og-se/ 2025-10-28T11:07:45+00:00 https://www.lmi.no/2025/10/28/storbritannia-verdens-storste-beslag-av-slankesproyter/ 2025-10-28T11:08:59+00:00 https://www.lmi.no/2025/10/28/vil-ikke-si-hva-nye-anbefalinger-kan-bety-for-hpv-anbud/ 2025-10-28T11:10:06+00:00 https://www.lmi.no/2025/10/29/fortsatt-ledige-plasser-pa-strategisamlingen/ 2025-10-29T08:39:22+00:00 https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/wp-content/uploads/2025/10/Stotvig-innsider-lavt-scaled.jpg https://www.lmi.no/2025/10/29/oncoinvent-fusjonen-naermer-seg/ 2025-10-29T09:09:38+00:00 https://www.lmi.no/2025/10/29/denne-vanlige-medisinen-kan-halvere-tilbakefall-av-tarmkreft/ 2025-10-29T09:10:21+00:00 https://www.lmi.no/2025/10/29/systemlojalitet-er-ikke-det-samme-som-systemkritikk/ 2025-10-29T09:11:40+00:00 https://www.lmi.no/2025/10/29/vi-kan-ikke-bygge-fremtidens-helsevesen-pa-mistillit/ 2025-10-29T09:14:53+00:00 https://www.lmi.no/2025/10/29/flere-nye-metodevurderinger-pa-vei-gront-lys-for-behandling-av-ultrasjelden-blodsykdom/ 2025-10-29T09:16:04+00:00 https://www.lmi.no/2025/10/29/vekst-til-tross-for-fedmefall-i-navamedic/ 2025-10-29T09:18:45+00:00 https://www.lmi.no/2025/10/29/sykehusinnkjop-fryktet-leverandorflukt-miljokrav-ga-uventet-effekt/ 2025-10-29T09:20:45+00:00 https://www.lmi.no/2025/10/29/vestre-ma-svare-om-helvetesild-vaksine-etter-mangel-pa-herpesmedisin/ 2025-10-29T09:22:32+00:00 https://www.lmi.no/2025/10/29/fda-opplever-historisk-hoy-medarbeiderflukt/ 2025-10-29T09:24:39+00:00 https://www.lmi.no/2025/10/29/roberto-oliveri-blir-ny-medisinsk-direktor-i-nykode/ 2025-10-29T09:25:28+00:00 https://www.lmi.no/2025/10/29/slankesproytebruk-oker-blant-norske-barn/ 2025-10-29T09:26:11+00:00 https://www.lmi.no/2025/10/29/schjesvold-om-blenrep-saken-beslutningsforum-bryter-med-sine-egne-prinsipper/ 2025-10-29T09:26:56+00:00 https://www.lmi.no/2025/10/29/mulighet-til-a-gi-innspill-pa-tehdas2-prosjektet/ 2025-10-29T13:00:16+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2024/12/Helsedata-AI-generert-Adobe-Stock-scaled.jpeg https://www.lmi.no/2025/10/30/nye-data-for-gsks-astmaspray-mener-selskapets-klimagassutslipp-kan-naer-halveres/ 2025-10-30T08:26:03+00:00 https://www.lmi.no/2025/10/30/anbudsstudien-viser-at-leverandorene-tas-pa-alvor/ 2025-10-30T08:27:03+00:00 https://www.lmi.no/2025/10/30/nye-data-for-gsks-astmaspray-mener-selskapets-klimagassutslipp-kan-naer-halveres-2/ 2025-10-30T08:28:41+00:00 https://www.lmi.no/2025/10/30/har-produsert-milliarder-av-doser-av-vekttapshap-for-godkjenning/ 2025-10-30T08:29:27+00:00 https://www.lmi.no/2025/10/30/photocure-oker-inntektene-og-forbedrer-lonnsomheten/ 2025-10-30T08:30:11+00:00 https://www.lmi.no/2025/10/30/ge-healthcare-oppjusterer-forventningene-rammes-av-tollpolitikk/ 2025-10-30T08:32:37+00:00 https://www.lmi.no/2025/10/30/f2f-medlemsmote-om-mfn/ 2025-10-31T11:26:11+00:00 https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/10/medlemsmote-politikk-scaled.jpg https://www.lmi.no/2025/10/31/healthtalk-nye-metoder-lege-omtaler-legemiddelindustrien-som-gradige-og-skruppellose-gir-dmp-rad-om-terskelverdi/ 2025-10-31T12:00:57+00:00 https://www.lmi.no/wp-content/uploads/2025/10/Skjermbilde-vester.png https://www.lmi.no/wp-content/uploads/2025/10/Skjermbilde-vester.png https://www.lmi.no/2025/10/31/dagens-medisin-ber-helseministeren-vurdere-nye-metoder-leges-habilitet/ 2025-10-31T12:01:50+00:00 https://www.lmi.no/wp-content/uploads/2025/10/dm-v.png https://www.lmi.no/wp-content/uploads/2025/10/dm-v.png https://www.lmi.no/2025/10/31/ibuprofen-far-bli-i-lua-ordningen-men-dmp-varsler-informasjonsloft/ 2025-10-31T12:02:38+00:00 https://www.lmi.no/2025/10/31/novo-nordisk-prover-a-overby-pfizer-i-biotek-avtale/ 2025-10-31T12:03:24+00:00 https://www.lmi.no/2025/10/31/tromso-selskap-bygger-legemiddelpipeline-fra-havet/ 2025-10-31T12:04:12+00:00 https://www.lmi.no/2025/10/31/ber-helseministeren-vurdere-nye-metoder-leges-habilitet/ 2025-10-31T12:05:00+00:00 https://www.lmi.no/2025/10/31/nye-metoder-lege-omtaler-legemiddelindustrien-som-gradige-og-skruppellose-gir-dmp-rad-om-terskelverdi/ 2025-10-31T12:06:21+00:00 https://www.lmi.no/2025/10/31/lmi-ber-vestre-vurdere-nye-metoder-medlems-habilitet-legen-slar-hardt-tilbake/ 2025-10-31T12:07:26+00:00 https://www.lmi.no/2025/11/03/dra-forums-medlemsmote/ 2025-11-03T10:34:45+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Gronn-helsetjeneste_AdobeStock_AI-generert-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/05/Sissel-Lonning-Andresen_Nomvec.jpg https://www.lmi.no/wp-content/uploads/2023/01/Anne-Margrethe-Hausken-Nordberg-6025-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/02/bente-scaled.jpg https://www.lmi.no/2025/11/03/reagerer-pa-industriens-habilitetskrav-viser-mangel-pa-forstaelse-for-ytringsfrihet/ 2025-11-03T11:16:25+00:00 https://www.lmi.no/2025/11/03/har-ingen-retningslinjer-for-ansattes-some-bruk-ytringfriheten-gjelder-ogsa-for-offentlig-ansatte/ 2025-11-03T11:17:32+00:00 https://www.lmi.no/2025/11/03/lmi-ber-vestre-vurdere-nye-metoder-medlems-habilitet-legen-slar-hardt-tilbake-2/ 2025-11-03T11:18:31+00:00 https://www.lmi.no/2025/11/03/nar-prioritering-blir-et-skjold-mot-kritikk/ 2025-11-03T11:19:42+00:00 https://www.lmi.no/2025/11/03/novo-holdings-er-medstifter-i-nytt-europeisk-milliardfond-for-vekstbedrifter/ 2025-11-03T11:20:37+00:00 https://www.lmi.no/2025/11/03/norsk-gjennombrudd-stor-betydning/ 2025-11-03T11:22:04+00:00 https://www.lmi.no/2025/11/03/vistin-pharma-satte-produksjonsrekord-lavere-priser-dempet-resultatet/ 2025-11-03T11:23:03+00:00 https://www.lmi.no/2025/11/03/eli-lilly-slo-forventningene-i-tredje-kvartal/ 2025-11-03T11:23:50+00:00 https://www.lmi.no/2025/11/03/faerre-leger-melder-bivirkninger-relis-frykter-at-viktige-faresignaler-kan-glippe/ 2025-11-03T11:24:46+00:00 https://www.lmi.no/2025/11/03/pfizer-klar-for-rettslige-skritt-mot-novo-nordisk-i-oppkjopsstrid/ 2025-11-03T11:25:50+00:00 https://www.lmi.no/2025/11/03/lmi-i-dagens-medisin-nar-prioritering-blir-et-skjold-mot-kritikk/ 2025-11-03T11:28:26+00:00 https://www.lmi.no/wp-content/uploads/2025/11/DM031125.png https://www.lmi.no/wp-content/uploads/2025/11/DM031125.png https://www.lmi.no/2025/11/03/nye-nesespray-rad-kan-spare-tusenvis-for-plager/ 2025-11-03T11:28:44+00:00 https://www.lmi.no/2025/11/03/advarer-gravide-om-ibuprofenbruk-%e2%81%a0-absolutt-ikke-i-de-siste-tre-manedene/ 2025-11-03T11:29:36+00:00 https://www.lmi.no/2025/11/03/utvikler-en-kur-mot-alle-de-farlige-virussykdommene/ 2025-11-03T11:30:37+00:00 https://www.lmi.no/2025/11/03/er-systemet-for-prioriteringer-bedre-enn-sitt-rykte/ 2025-11-03T11:31:39+00:00 https://www.lmi.no/2025/11/03/bransjeleder-usa-kan-miste-biotek-ledelsen-til-kina-innen-to-ar/ 2025-11-03T11:32:28+00:00 https://www.lmi.no/2025/11/03/pfizer-gar-til-sak-mot-metsera-og-novo-nordisk/ 2025-11-03T11:33:41+00:00 https://www.lmi.no/2025/11/05/rootwelt-forsvarer-vester-har-full-tillit-til-jobben-som-gjores/ 2025-11-05T10:05:59+00:00 https://www.lmi.no/2025/11/05/novo-nordisks-kapring-av-biotek-oppkjop-kan-mote-trump-motstand/ 2025-11-05T10:06:51+00:00 https://www.lmi.no/2025/11/05/nasjonalt-eksportrad-vil-unnga-ny-spinchip-smell-har-levert-ti-onsker-til-regjeringen/ 2025-11-05T10:07:39+00:00 https://www.lmi.no/2025/11/05/helseminister-vestre-lovet-hap-systemet-leverer-taushet/ 2025-11-05T10:08:49+00:00 https://www.lmi.no/2025/11/05/sykehusinnkjop-taus-om-de-ga-gsk-prisrad/ 2025-11-05T10:14:45+00:00 https://www.lmi.no/2025/11/05/budkrigen-raser-novo-nordisk-overbyr-pfizer-i-nytt-bud-pa-metsera/ 2025-11-05T10:15:32+00:00 https://www.lmi.no/2025/11/05/novo-nordisk-avviser-pfizer-anklager-absurd-og-ikke-basert-pa-fakta/ 2025-11-05T10:16:24+00:00 https://www.lmi.no/2025/11/05/frp-krav-fradrag-pa-selvangivelsen-for-legemidler-som-betales-privat/ 2025-11-05T10:17:13+00:00 https://www.lmi.no/2025/11/05/ny-svensk-alzheimer-kandidat-til-fase-3/ 2025-11-05T10:19:31+00:00 https://www.lmi.no/2025/11/05/nordmannen-leder-europas-legemiddelvakt-et-nesten-feilfritt-system/ 2025-11-05T10:20:46+00:00 https://www.lmi.no/2025/11/05/ottersen-far-europeisk-toppverv/ 2025-11-05T10:21:55+00:00 https://www.lmi.no/2025/11/05/astra-zeneca-aksjonaerer-stemmer-for-new-york-notering/ 2025-11-05T10:22:38+00:00 https://www.lmi.no/2025/11/05/roche-satte-verdensrekord-sekvenserte-menneskelig-genom-pa-under-fire-timer/ 2025-11-05T10:23:39+00:00 https://www.lmi.no/2025/11/05/schjesvold-mener-sykehusinnkjop-har-regnet-feil-pa-blenrep/ 2025-11-05T10:24:22+00:00 https://www.lmi.no/2025/11/05/pfizer-oppjusterer-etter-bedre-enn-ventet-tredje-kvartal/ 2025-11-05T10:25:11+00:00 https://www.lmi.no/2025/11/05/den-danske-farmasigiganten-novo-nordisk-legger-frem-skuffende-resultater/ 2025-11-05T10:25:54+00:00 https://www.lmi.no/2025/11/03/helsedataprosjektet-valo-et-viktig-steg-i-retning-nordisk-helsedatasamarbeid/ 2025-11-05T11:42:40+00:00 https://www.lmi.no/wp-content/uploads/2025/11/VALO_Aslaug-pa-scenen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Helsedata-Norge-Norden-AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/VALO_Aslaug-pa-scenen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/VALO_Nicolas-i-panel-scaled.jpg https://www.lmi.no/2025/11/06/blodkreftforeningen-krever-gjennomgang-etter-blenrep-avslag-pasientene-blir-skadelidende-av-rot-og-uklarhet/ 2025-11-06T08:17:56+00:00 https://www.lmi.no/2025/11/06/ottersen-far-europeisk-toppverv-2/ 2025-11-06T08:18:50+00:00 https://www.lmi.no/2025/11/06/nykode-med-nytt-patent-og-ki-data-vi-skal-vaere-det-beste-alternativet/ 2025-11-06T08:19:51+00:00 https://www.lmi.no/2025/11/06/novo-nordisk-kutter-i-forventningene-til-aret/ 2025-11-06T08:20:56+00:00 https://www.lmi.no/2025/11/06/helseindustrien-vokser-men-norges-eksport-hviler-pa-en-bedrift/ 2025-11-06T08:22:27+00:00 https://www.lmi.no/2025/11/06/debatt-nar-globale-analyser-ikke-ma-oversettes-til-norsk-virkelighet/ 2025-11-06T08:24:41+00:00 https://www.lmi.no/2025/11/06/norsk-helseeksport-i-sneglefart-2030-malet-kan-sprekke/ 2025-11-06T08:25:30+00:00 https://www.lmi.no/2025/11/06/vi-taper-tid-i-eksportkapplopet/ 2025-11-06T08:26:37+00:00 https://www.lmi.no/2025/11/06/thor-medical-inngar-avtale-med-radiofarmasi-selskap/ 2025-11-06T08:27:25+00:00 https://www.lmi.no/2025/11/06/dommer-ser-ikke-behov-for-rettsbehandling-av-budkrigen-mellom-pfizer-og-novo-nordisk/ 2025-11-06T08:28:28+00:00 https://www.lmi.no/2025/11/06/schjesvold-mener-sykehusinnkjop-har-regnet-feil-pa-blenrep-2/ 2025-11-06T08:30:07+00:00 https://www.lmi.no/2025/11/06/sykehusinnkjop-taus-om-de-ga-gsk-prisrad-2/ 2025-11-06T08:30:59+00:00 https://www.lmi.no/2025/11/06/lmi-advokaten-ytringer-kan-gjore-deg-inhabil/ 2025-11-06T08:38:24+00:00 https://www.lmi.no/2025/11/06/lmi-advokaten-ytringer-kan-gjore-deg-inhabil-2/ 2025-11-06T08:50:10+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Haaskjold_DagensMedisin.png https://www.lmi.no/wp-content/uploads/2025/11/Haaskjold_DagensMedisin.png https://www.lmi.no/2025/11/07/habilitetsstriden-hod-vilikke-behandle-lmi-brevet/ 2025-11-07T11:45:41+00:00 https://www.lmi.no/2025/11/07/vester-anklager-lmi-for-dobbeltmoral-etter-habilitetskritikk/ 2025-11-07T11:46:31+00:00 https://www.lmi.no/2025/11/07/ge-healthcare-toppsjefen-styrer-halvparten-av-norsk-helseeksport-na-er-hun-ekstremt-utalmodig/ 2025-11-07T11:47:27+00:00 https://www.lmi.no/2025/11/07/forebyggende-behandling-av-migrene-en-av-fire-trenger-det-kun-en-av-ti-far-det/ 2025-11-07T11:48:16+00:00 https://www.lmi.no/2025/11/07/astra-zeneca-overgar-forventninger-for-omsetning-og-resultat/ 2025-11-07T11:49:00+00:00 https://www.lmi.no/2025/11/07/screening-av-prostatakreft-kan-redde-liv-men-overlege-advarer-om-overdiagnostikk-og-overbehandling/ 2025-11-07T11:49:45+00:00 https://www.lmi.no/2025/11/07/novo-nordisk-og-eli-lilly-inngar-prisavtale-med-trump-lavere-priser-pa-glp-1-medisiner/ 2025-11-07T11:50:33+00:00 https://www.lmi.no/2025/11/07/kronikk-norsk-helseeksport-star-stille/ 2025-11-07T11:57:00+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Skjermbilde-2025-11-07-125232.png https://www.lmi.no/wp-content/uploads/2025/11/Skjermbilde-2025-11-07-125232.png https://www.lmi.no/2025/11/07/livsvitenskapskonferansen-2026-investeringer-for-fremtiden/ 2025-11-07T14:27:02+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Norway-Life-Science-2026-front-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/11/banner%E2%80%93artikkel%E2%80%93livsvitenskapskonferansen-2026-1000x562-1.jpg https://www.lmi.no/2025/11/10/sykehusinnkjop-peker-pa-beslutningsforum-for-vurdering-av-klinisk-relevans-i-blenrep-saken/ 2025-11-10T08:17:38+00:00 https://www.lmi.no/2025/11/10/norway-health-tech-lederen-blir-toppsjef-i-medtek-selskap/ 2025-11-10T08:20:08+00:00 https://www.lmi.no/2025/11/10/novo-nordisk-toppsjefen-til-trump-takk-for-at-du-gjor-amerika-stort-igjen/ 2025-11-10T08:20:58+00:00 https://www.lmi.no/2025/11/10/calluna-pharma-far-sjelden-fordel-av-amerikanske-myndigheter/ 2025-11-10T08:21:40+00:00 https://www.lmi.no/2025/11/10/ferdig-etter-11-ar-i-bayer-legger-ned-kommunikasjonsavdelingen-i-norge/ 2025-11-10T08:22:27+00:00 https://www.lmi.no/2025/11/10/sjefen-i-roche-norge-slutter/ 2025-11-10T08:23:09+00:00 https://www.lmi.no/2025/11/10/novo-nordisk-taper-dramatisk-budkrig-mot-pfizer/ 2025-11-10T08:25:31+00:00 https://www.lmi.no/2025/11/10/dmp-har-ingen-mening-om-hva-michael-vester-publiserer-pa-sosiale-medier/ 2025-11-10T08:26:21+00:00 https://www.lmi.no/2025/11/10/debatt-tre-ubesvarte-sporsmal-om-prioritering/ 2025-11-10T08:27:24+00:00 https://www.lmi.no/2025/11/10/oljefondet-stotter-ikke-styreforslag-i-novo-nordisk/ 2025-11-10T08:28:04+00:00 https://www.lmi.no/2025/11/10/gode-lytix-resultater-lagt-frem-pa-kongress/ 2025-11-10T08:28:45+00:00 https://www.lmi.no/2025/11/10/omvisning-hos-halden-pharma-for-strategisamlingen/ 2025-11-10T12:50:56+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Halden-Pharma-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Halden-Pharma-scaled.jpg https://www.lmi.no/2025/11/11/hod-ber-helse-sor-ost-ordne-opp-selv-skal-vurdere-habiliteten/ 2025-11-11T10:29:44+00:00 https://www.lmi.no/2025/11/11/departementet-sender-habilitetssak-til-helse-sor-ost-direktor-har-allerede-uttrykt-full-tillit-til-michael-vester/ 2025-11-11T10:30:49+00:00 https://www.lmi.no/2025/11/11/denne-medisinen-bor-du-ikke-kaste-i-toalettet/ 2025-11-11T10:33:07+00:00 https://www.lmi.no/2025/11/11/ny-studie-utbredte-legemidler-kan-etterlate-seg-negative-spor-i-tarmen-i-arevis/ 2025-11-11T10:36:08+00:00 https://www.lmi.no/2025/11/11/rootwelt-innrommer-beslutningsforum-baserte-blenrep-avslag-pa-utdatert-dosering/ 2025-11-11T10:36:48+00:00 https://www.lmi.no/2025/11/11/den-siste-tiden-har-det-vaert-mer-tilspisset-krangling-offentlig-det-synes-jeg-er-dumt/ 2025-11-11T10:37:31+00:00 https://www.lmi.no/2025/11/11/brukes-som-sovnmedisin-flere-unge-innlagt-etter-overdoser/ 2025-11-11T10:38:15+00:00 https://www.lmi.no/2025/11/11/roches-utprovende-ms-medisin-nar-hovedmal-i-sentrale-studier/ 2025-11-11T10:38:59+00:00 https://www.lmi.no/2025/11/11/positive-resultater-i-lytix-biopharmas-foflekkreftstudie-ved-radiumhospitalet/ 2025-11-11T10:39:37+00:00 https://www.lmi.no/2025/11/12/medicon-valley-blant-europas-fremste-life-science-klynger/ 2025-11-12T11:10:24+00:00 https://www.lmi.no/2025/11/12/disse-orsma-virusene-gir-hap-i-kampen-mot-okt-antibiotikaresistens/ 2025-11-12T11:12:51+00:00 https://www.lmi.no/2025/11/12/msd-pcsk9-hemmer-i-tablettform-viser-lovende-resultater/ 2025-11-12T11:18:16+00:00 https://www.lmi.no/2025/11/12/norsk-studie-skal-teste-car-t-mot-prostatakreft-rekrutterer-pasienter-fra-hele-landet/ 2025-11-12T11:19:06+00:00 https://www.lmi.no/2025/11/12/workshop-om-mfn/ 2025-11-12T11:42:20+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Mote_gruppearbeid_pasienkontakt_workshop_samarbeid-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/05/Mote_gruppearbeid_pasienkontakt_workshop_samarbeid-scaled.jpeg https://www.lmi.no/2025/11/13/gsk-svarer-rootwelt-haper-at-vi-sammen-skal-finne-en-losning/ 2025-11-13T10:30:45+00:00 https://www.lmi.no/2025/11/13/eli-lilly-runder-viktig-milepael-kursen-gar-over-1000-dollar-for-forste-gang/ 2025-11-13T10:31:35+00:00 https://www.lmi.no/2025/11/13/produksjonen-hardest-rammet-av-novo-nordisk-kuttene/ 2025-11-13T10:32:26+00:00 https://www.lmi.no/2025/11/13/norsk-selskap-styrker-posisjonen-innen-radiofarmasi/ 2025-11-13T10:33:43+00:00 https://www.lmi.no/2025/11/13/ny-oppgjorslosning-for-blareseptlegemidler-med-hemmelige-priser-lagt-pa-is/ 2025-11-13T10:37:51+00:00 https://www.lmi.no/2025/11/13/vil-sikre-norsk-produksjon-og-arbeidsplasser/ 2025-11-13T10:42:43+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Legemiddelindustrien-samlet-i-Sarpsborgs-fylkeshus.jpg https://www.lmi.no/wp-content/uploads/2025/11/Legemiddelindustrien-samlet-i-Sarpsborgs-fylkeshus.jpg https://www.lmi.no/2025/11/13/lmi-pa-plass-pa-farmasidagene/ 2025-11-13T12:08:09+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/agilera-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Curida-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Bente-scaled.jpg https://www.lmi.no/2025/11/14/blir-det-mer-innovasjon-av-hoye-medisinpriser-fire-aktorer-svarer/ 2025-11-14T12:41:09+00:00 https://www.lmi.no/2025/11/14/ny-studie-store-forskjeller-mellom-ulike-antidepressive-legemidler/ 2025-11-14T12:42:58+00:00 https://www.lmi.no/2025/11/14/eldre-og-skropelige-pasienter-taler-omfattende-behandling-av-benmargskreft-godt/ 2025-11-14T12:44:02+00:00 https://www.lmi.no/2025/11/14/fransk-ekspert-haper-pa-bedre-medisin-tilgang-for-norske-myelomatosepasienter/ 2025-11-14T12:44:49+00:00 https://www.lmi.no/2025/11/14/fda-apner-ny-vei-for-persontilpasset-medisin/ 2025-11-14T12:45:59+00:00 https://www.lmi.no/2025/11/14/fagdirektor-om-tilgangsordningen-tunge-prosesser-og-uklare-begreper/ 2025-11-14T12:47:50+00:00 https://www.lmi.no/2025/11/14/titusenvis-av-barn-bor-vaksineres-kan-slippe-sproyter/ 2025-11-14T12:48:52+00:00 https://www.lmi.no/2025/11/17/nasjonal-mangel-pa-kraftig-kvisemedisin/ 2025-11-17T07:33:00+00:00 https://www.lmi.no/2025/11/17/leter-etter-sammenheng-mellom-medisinbruk-og-demens/ 2025-11-17T07:34:14+00:00 https://www.lmi.no/2025/11/17/har-valgt-ny-styreleder-i-novo-nordisk/ 2025-11-17T07:35:16+00:00 https://www.lmi.no/2025/11/17/ema-panel-apner-for-ti-nye-behandlinger-i-europa/ 2025-11-17T07:36:17+00:00 https://www.lmi.no/2025/11/17/storbritannia-godkjenner-nytt-behandlingsregime-for-bioarctics-alzheimer-legemiddel/ 2025-11-17T07:37:21+00:00 https://www.lmi.no/2025/11/17/lege-advarer-mot-feil-bruk-av-vitamin-d-veldig-farlig/ 2025-11-17T07:38:26+00:00 https://www.lmi.no/2025/11/17/ny-pasientlov-vil-gjore-rettighetene-til-pasientene-tydeligere/ 2025-11-17T07:39:30+00:00 https://www.lmi.no/2025/11/17/flere-dodsfall-covid-19-kan-gi-hoyt-blodtrykk/ 2025-11-17T07:41:36+00:00 https://www.lmi.no/2025/11/17/industrisamarbeid-avtale-som-sikrer-apenhet-vil-vaere-bra-for-hele-spesialisthelsetjenesten/ 2025-11-17T07:45:20+00:00 https://www.lmi.no/2025/11/17/reagerer-kraftig-pa-kampanje-foler-at-vi-er-tikkende-bomber/ 2025-11-17T07:53:01+00:00 https://www.lmi.no/2025/11/17/helge-lund-takket-for-seg-med-et-stikk-til-novo-nordisk-fonden/ 2025-11-17T08:21:22+00:00 https://www.lmi.no/2025/11/17/pris-og-effekt-i-spill-nar-beslutningsforum-vurderer-tre-nye-kreftbehandlinger/ 2025-11-17T08:22:35+00:00 https://www.lmi.no/2025/11/17/arets-farmasoyt-er-begeistret-og-bekymret-for-kunstig-intelligens/ 2025-11-17T08:24:32+00:00 https://www.lmi.no/2025/11/17/anbefaler-a-godkjenne-forste-behandling-som-kan-bremse-type-1-diabetes/ 2025-11-17T08:26:03+00:00 https://www.lmi.no/2025/11/17/lmi-deltok-pa-ifpma-council-mfn-og-global-helse-preget-agendaen/ 2025-11-17T11:17:52+00:00 https://www.lmi.no/wp-content/uploads/2025/11/LMI-IFPMA-Council-Meeting-edited.jpg https://www.lmi.no/wp-content/uploads/2025/11/LMI-IFPMA-Council-Meeting-edited.jpg https://www.lmi.no/wp-content/uploads/2025/11/Mote-med-ambassador-til-FN-Geneve-1.jpg https://www.lmi.no/2025/11/17/kan-eldrebolgen-bli-en-eldrekraft-hvis-vi-blir-bedre-pa-forebygging/ 2025-11-17T12:21:42+00:00 https://www.lmi.no/wp-content/uploads/2025/11/AdobeStock_235550310-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/Eldre-hjemme-parorende-AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/Anne-Margrethe-Helsedagen-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Anbefalte-vaksiner-fhi-ny.png https://www.lmi.no/2025/11/18/merker-okt-forekomst-av-helvetesild-mange-vaksinerer-seg/ 2025-11-18T09:19:12+00:00 https://www.lmi.no/2025/11/18/tvilsom-verdi-av-hoy-levealder/ 2025-11-18T09:21:22+00:00 https://www.lmi.no/2025/11/18/dmp-har-vurdert-bla-resept-for-wegovy-pristilbud-gjor-behandlingen-kostnadseffektiv/ 2025-11-18T09:23:24+00:00 https://www.lmi.no/2025/11/18/marie-gikk-med-magesmerter-i-seks-ar-for-hun-fikk-svar-gammel-blir-du-nok-ikke/ 2025-11-18T09:24:41+00:00 https://www.lmi.no/2025/11/18/vanlig-stoff-mot-sovnloshet-kan-oke-risiko-for-hjertesvikt/ 2025-11-18T09:28:01+00:00 https://www.lmi.no/2025/11/18/oppdrettsgigant-brukte-antibiotika-fire-ar-pa-rad-men-skrev-noe-helt-annet-pa-egne-nettsider-bare-a-beklage/ 2025-11-18T09:29:14+00:00 https://www.lmi.no/2025/11/18/om-fem-ar-har-vi-fatt-klinikerne-til-a-blomstre-og-snudd-legeflukten/ 2025-11-18T09:31:26+00:00 https://www.lmi.no/2025/11/18/hvorfor-forlater-folk-norge-en-av-grunnene-er-misnoye-med-helsevesenet/ 2025-11-18T09:41:11+00:00 https://www.lmi.no/2025/11/18/na-kan-ahus-teste-for-alzheimers-g-jennom-blodprover/ 2025-11-18T10:04:57+00:00 https://www.lmi.no/2025/11/18/elever-laerte-om-farene-ved-antibiotikaresistens/ 2025-11-18T10:08:11+00:00 https://www.lmi.no/2025/11/18/johnson-johnson-kjoper-kreftselskap-for-over-30-milliarder-kroner/ 2025-11-18T10:09:55+00:00 https://www.lmi.no/2025/11/18/forskning-kan-endre-oppfolgingen-av-hjertepasienter/ 2025-11-18T10:11:11+00:00 https://www.lmi.no/2025/11/18/dmp-om-nettkampanjer-etter-novo-nordisk-kritikk-ikke-i-grasone/ 2025-11-18T10:12:04+00:00 https://www.lmi.no/2025/11/18/skaper-milliardindustri-i-oslo/ 2025-11-18T10:16:26+00:00 https://www.lmi.no/2025/11/18/radioaktive-legemidler-er-tema-i-siste-nummer-av-apollon/ 2025-11-18T10:56:15+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Apollon-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Apollon-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Apollon-2-scaled.jpg https://www.lmi.no/2025/11/18/arets-farmasoyt-er-begeistret-og-bekymret-for-kunstig-intelligens-3/ 2025-11-18T11:07:32+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Bente-i-Farmatid-nov-25.png https://www.lmi.no/wp-content/uploads/2025/11/Bente-i-Farmatid-nov-25.png https://www.lmi.no/2025/11/18/circio-inngar-samarbeidsavtale-med-global-farmagigant/ 2025-11-18T11:10:41+00:00 https://www.lmi.no/2025/11/18/alt-tyder-pa-blenrep-innforing-for-jul-rootwelt-og-gsk-naermer-seg-losning/ 2025-11-18T11:12:17+00:00 https://www.lmi.no/2025/11/18/lytix-biopharma-naermer-seg-kommersialisering-av-legemiddel/ 2025-11-18T11:14:46+00:00 https://www.lmi.no/2025/11/19/inlifescience-2025-det-haster-a-legge-til-rette-for-investeringer-og-lansering-av-nye-legemidler/ 2025-11-21T08:20:21+00:00 https://www.lmi.no/wp-content/uploads/2025/11/InLifeScience2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/InLifeScience2025-scaled.jpg https://www.lmi.no/2025/11/21/politikerne-skal-vurdere-om-fedmemedisin-skal-gis-pa-bla-resept-det-betyr-alt/ 2025-11-21T10:40:15+00:00 https://www.lmi.no/2025/11/21/msds-orale-pcsk9-hemmer-viser-opptil-60-prosent-ldl-reduksjon-i-fase-3-studier/ 2025-11-21T10:41:07+00:00 https://www.lmi.no/2025/11/21/johaug-gar-hardt-ut-mot-sveriges-sponsor-strider-mot-alt-jeg-star-for/ 2025-11-21T10:42:01+00:00 https://www.lmi.no/2025/11/21/potensmiddel-blir-reseptfritt-fra-nyttar/ 2025-11-21T10:42:52+00:00 https://www.lmi.no/2025/11/21/det-viktigste-vi-kan-gjore-er-a-bruke-antibiotika-sa-lite-som-mulig/ 2025-11-21T10:43:49+00:00 https://www.lmi.no/2025/11/21/roche-far-gode-studiedata-med-brystkreft-pille/ 2025-11-21T10:44:55+00:00 https://www.lmi.no/2025/11/21/kreftselskapet-star-stott-vi-har-ikke-darlig-tid-med-a-hente-penger/ 2025-11-21T10:45:51+00:00 https://www.lmi.no/2025/11/21/novartis-far-gront-lys-for-utvidet-indikasjon-for-kreftmedisin-satser-pa-refusjon-i-forstelinje/ 2025-11-21T10:46:42+00:00 https://www.lmi.no/2025/11/21/onkologisk-forum-samler-kreft-norge-moteplassen-med-stor-m/ 2025-11-21T10:47:43+00:00 https://www.lmi.no/2025/11/21/asamedic-inngar-avtale-med-internasjonalt-legemiddelselskap/ 2025-11-21T10:48:36+00:00 https://www.lmi.no/2025/11/21/har-ventet-i-fire-ar-endelig-er-det-hap/ 2025-11-21T10:49:19+00:00 https://www.lmi.no/2025/11/21/kan-migrene-kureres-en-ny-behandling-viser-lovende-resultater/ 2025-11-21T10:50:16+00:00 https://www.lmi.no/2025/11/21/ny-medisin-hvert-minutt-teller/ 2025-11-21T10:51:02+00:00 https://www.lmi.no/2025/11/21/thor-medical-sikrer-femarig-avtale-med-nuclithera/ 2025-11-21T10:51:48+00:00 https://www.lmi.no/2025/11/21/regjeringen-svarer-om-treg-helseeksport-vi-har-gode-bedrifter/ 2025-11-21T10:52:34+00:00 https://www.lmi.no/2025/11/21/norske-ms-forskarar-med-gjennombrot-gjev-hap/ 2025-11-21T10:54:10+00:00 https://www.lmi.no/2025/11/21/prisvinner-karl-johan-malmberg-om-nk-cellene-kroppens-egne-seriemordere/ 2025-11-21T10:54:59+00:00 https://www.lmi.no/2025/11/21/teva-jakter-startups-skal-investere-titalls-millioner-i-nye-losninger/ 2025-11-21T10:56:04+00:00 https://www.lmi.no/2025/11/21/eu-sier-ja-til-subkutan-keytrudaeu-kommisjonen-har-godkjent-mercks-keytruda-sc-som-er-den-forste-subkutane-versjonen-av-den-storselgende-immunterapien/ 2025-11-21T10:57:14+00:00 https://www.lmi.no/2025/11/21/trening-kan-bli-standard-kreftbehandling-en-game-changer/ 2025-11-21T10:58:05+00:00 https://www.lmi.no/2025/11/21/novartis-forventer-vekst-pa-5-6-prosent-pa-mellomlang-sikt/ 2025-11-21T10:59:06+00:00 https://www.lmi.no/2025/11/24/studieapp-gjor-det-enkelt-for-onkologene-a-finne-kliniske-studier-til-pasientene/ 2025-11-24T08:37:46+00:00 https://www.lmi.no/2025/11/24/dette-bildet-vakte-reaksjoner-men-det-er-ikke-slankegigantens-eneste-problem/ 2025-11-24T08:38:47+00:00 https://www.lmi.no/2025/11/24/moderna-vil-investere-over-14-milliarder-kroner-i-usa/ 2025-11-24T08:42:15+00:00 https://www.lmi.no/2025/11/24/ge-healthcare-har-doblet-antall-fou-ansatte-i-norge/ 2025-11-24T08:42:56+00:00 https://www.lmi.no/2025/11/24/alzheimer-data-fra-novo-nordisk-naermer-seg/ 2025-11-24T08:44:08+00:00 https://www.lmi.no/2025/11/24/nei-til-livreddende-behandling-i-norge-%e2%81%a0-helt-utrolig/ 2025-11-24T08:44:53+00:00 https://www.lmi.no/2025/11/24/atvarar-mot-gammal-antibiotika-vil-gjere-oss-resistente/ 2025-11-24T08:46:01+00:00 https://www.lmi.no/2025/11/24/na-er-antibiotikakurene-kortere/ 2025-11-24T08:46:47+00:00 https://www.lmi.no/2025/11/24/prognosene-er-elendige-laila-nektet-a-gi-seg/ 2025-11-24T11:34:28+00:00 https://www.lmi.no/2025/11/24/coliaki-studie-%e2%81%a0-det-gir-hap/ 2025-11-24T11:37:13+00:00 https://www.lmi.no/2025/11/24/passerer-1000-milliarder-dollar-i-verdi-som-det-forste-legemiddelselskapet-noensinne/ 2025-11-24T11:38:29+00:00 https://www.lmi.no/2025/11/24/ny-strategi-i-behandling-av-brystkreft-esr1-mutasjon-avslorer-resistens-for-den-blir-synlig/ 2025-11-24T11:40:04+00:00 https://www.lmi.no/2025/11/20/vi-ma-handle-na-hvis-norge-fortsatt-skal-vaere-ledende-innen-radiofarmasi/ 2025-11-24T17:44:47+00:00 https://www.lmi.no/wp-content/uploads/2025/11/FotoYngveVogt_2025_IMGL8858-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/FotoYngveVogt_2025_IMGL8858-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/FotoYngveVogt_2025_IMGL8591-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/FotoYngveVogt_2025_IMGL8618-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/FotoYngveVogt_2025_IMGL8725-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/FotoYngveVogt_2025_IMGL8536-scaled.jpg https://www.lmi.no/2025/11/25/advarer-mot-urealistisk-studieambisjon-hele-systemet-ma-styrkes/ 2025-11-25T08:12:08+00:00 https://www.lmi.no/2025/11/26/dnb-nordic-healthcare-conference-norge-har-et-valg-a-ta/ 2025-11-26T09:12:47+00:00 https://www.lmi.no/wp-content/uploads/2025/11/DNB-Nordic-Healthcare-Conference-2025.jpg https://www.lmi.no/wp-content/uploads/2025/11/DNB-Nordic-Healthcare-Conference-2025.jpg https://www.lmi.no/2023/09/11/livsviktig-eksportsatsing-2/ 2025-11-26T09:32:59+00:00 https://www.lmi.no/wp-content/uploads/2021/03/Sanofi-vaksineproduksjon2.jpg https://www.lmi.no/2024/08/29/kommunikasjon-og-events/ 2025-11-26T10:24:48+00:00 https://www.lmi.no/wp-content/uploads/2018/08/ansattbilder-crop-5984-scaled.jpg https://www.lmi.no/wp-content/uploads/2018/08/ansattbilder-crop-5599-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Ase-Solberg-crop-6248.jpg https://www.lmi.no/wp-content/uploads/2024/04/Ina-T_crop-edited-1.jpg https://www.lmi.no/wp-content/uploads/2023/10/Lisa-Bergestad-6061-scaled-ny.jpg https://www.lmi.no/2024/11/20/legemiddelindustrien-er-viktig-for-fremtidens-norge/ 2025-11-26T10:25:50+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde-av-slide-2.png https://www.lmi.no/wp-content/uploads/2024/11/skjerbilde-av-slide-3.png https://www.lmi.no/wp-content/uploads/2024/11/skjermbilde-av-slide-4.png https://www.lmi.no/wp-content/uploads/2024/11/Helsedata_ny-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/11/Skjermbilde-av-slide-19.png https://www.lmi.no/wp-content/uploads/2024/11/Hallsjodammen_Foto-Olav-Skjorten_Norges-vassdrags-og-energidirektorat.jpg https://www.lmi.no/wp-content/uploads/2024/11/Oljeboring_Foto-Knudsens-Fotosenter_Dextra-Photo-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/1_Agnete-Fredriksen_Foto-Eline-Feiring-LMI.jpeg https://www.lmi.no/wp-content/uploads/2024/11/2_Olaf-Weider_foto-Cygnus.png https://www.lmi.no/2025/11/26/novo-nordisk-aksjen-stuper-pa-skuffende-nyheter/ 2025-11-26T10:48:18+00:00 https://www.lmi.no/2025/11/26/bayer-deler-positive-fase-3-data-med-kandidat-mot-hjerneslag/ 2025-11-26T10:49:23+00:00 https://www.lmi.no/2025/11/26/circio-har-kvittet-seg-med-gjeld-men-ma-fylle-kassen-for-varen/ 2025-11-26T10:50:07+00:00 https://www.lmi.no/2025/11/26/nykode-ser-effekt-av-kutt/ 2025-11-26T10:50:47+00:00 https://www.lmi.no/2025/11/26/tapte-over-1245-milliarder-kroner-i-markedsverdi-etter-mislykket-alzheimer-studie/ 2025-11-26T10:51:31+00:00 https://www.lmi.no/2025/11/26/ge-healthcare-kjoper-programvareselskap/ 2025-11-26T10:52:13+00:00 https://www.lmi.no/2025/11/26/katrin-kleinmanns-tildelt-onkologisk-forums-ung-forsker-pris/ 2025-11-26T10:53:00+00:00 https://www.lmi.no/2025/11/26/ny-milliardinvestering-for-astrazeneca-i-usa/ 2025-11-26T10:53:40+00:00 https://www.lmi.no/2025/11/26/tommer-hyllene-for-influensavaksine/ 2025-11-26T10:57:07+00:00 https://www.lmi.no/2025/11/26/vaksinebeskjed-na-haster-det/ 2025-11-26T10:57:58+00:00 https://www.lmi.no/2025/11/26/bergensselskap-sikrer-156-millioner-kroner-til-utvikling-av-legemiddelkandidat/ 2025-11-26T10:58:40+00:00 https://www.lmi.no/2025/11/26/novo-nordisks-amycretin-viser-vekttap-pa-opptil-145-prosent/ 2025-11-26T10:59:22+00:00 https://www.lmi.no/2025/11/26/kreftlegar-utanfor-austlandet-i-oppror-mot-kreftforeningen/ 2025-11-26T10:59:59+00:00 https://www.lmi.no/2025/11/26/novo-nordisk-aksjen-stiger-etter-nye-testresultater/ 2025-11-26T11:00:38+00:00 https://www.lmi.no/2025/11/26/etter-masseoppsigelser-fda-skal-fremskynde-vurderingsprosesser-med-nye-ansatte/ 2025-11-26T11:01:20+00:00 https://www.lmi.no/2025/11/26/lytix-partner-henter-500-millioner-kroner-skal-slette-gjeld-og-viderefinansiere-studier/ 2025-11-26T11:02:08+00:00 https://www.lmi.no/2025/11/26/forste-pasient-behandlet-i-artbio-studie/ 2025-11-26T11:02:53+00:00 https://www.lmi.no/2025/11/26/budskap-mfn/ 2025-11-26T11:43:51+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Most-Favored-Nation_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/Most-Favored-Nation_AdobeStock-scaled.jpeg https://www.lmi.no/2025/11/06/eksport-fra-helseindustrien-pa-stedet-hvil/ 2025-11-26T13:11:03+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Helseeksport-frokostmote-061125-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Helseeksport-frokostmote-061125-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Menon-helseeksport-frokostmote-061125-scaled.jpg https://www.lmi.no/2025/11/26/forste-mote-i-mfn-ekspertgruppe/ 2025-11-26T13:56:24+00:00 https://www.lmi.no/wp-content/uploads/2025/11/front-mfn-front.jpg https://www.lmi.no/wp-content/uploads/2025/11/dump-2-kopi.jpg https://www.lmi.no/2025/11/27/lanserer-digital-fullmakt-for-resepter-gjor-det-enklere-a-vaere-foreldre/ 2025-11-27T11:16:10+00:00 https://www.lmi.no/2025/11/27/roche-i-sveits-forste-kunde-for-norsk-varmepumpeselskap/ 2025-11-27T11:17:14+00:00 https://www.lmi.no/2025/11/27/kurzrock-vi-ma-rive-ned-gamle-regler-for-a-gi-kreftpasienter-bedre-behandling/ 2025-11-27T11:18:14+00:00 https://www.lmi.no/2025/11/27/forsker-en-detalj-i-novo-nordisks-alzheimer-studie-etterlater-et-lite-glimt-av-hap/ 2025-11-27T11:19:03+00:00 https://www.lmi.no/2025/11/27/msd-stotte-kutter-nykodes-kostnader-med-hundre-millioner-kroner/ 2025-11-27T11:19:54+00:00 https://www.lmi.no/2025/11/27/disse-kreftforskerne-far-millioner-fra-kreftforeningen/ 2025-11-27T11:21:09+00:00 https://www.lmi.no/2025/11/27/hvorfor-bor-norske-leger-fa-delta-i-advisory-board/ 2025-11-27T11:27:08+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Advisory-board-collage.png https://www.lmi.no/wp-content/uploads/2025/11/Jon-Riise_portrett-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Petter-Brandal_portrett-1-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Advisory-board_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/Synnove-Jespersen-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Nicolas-Vaugelade-Baust-scaled.jpg https://www.lmi.no/2025/11/27/utlysning-nominer-kandidater-til-lmis-nye-komiteer-og-advisory-boards/ 2025-11-27T14:50:48+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Utvalg-illustrasjon_-AdobeStock-1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/Utvalg-illustrasjon_-AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/11/Komiteer-og-advisory-boards.png https://www.lmi.no/2025/11/17/prisutdeling-prisen-for-fremragende-innsats-innen-kliniske-studier-2025/ 2025-11-28T09:38:44+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/11/Kliniske-studier-prisen_ill-scaled.png https://www.lmi.no/wp-content/uploads/2024/09/Ina-Dahlsveen-crop-1.png https://www.lmi.no/wp-content/uploads/2022/09/Signe-Oien-Fretland-HIGHRES-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Vestre-crop.png https://www.lmi.no/2025/11/28/det-verste-vi-har-vaert-med-pa/ 2025-11-28T10:39:14+00:00 https://www.lmi.no/2025/11/28/ny-studie-forskere-kan-ha-funnet-bade-arsaken-til-og-losningen-pa-en-av-de-mest-hjerteskjaerende-konsekvensene-av-alzheimer/ 2025-11-28T10:40:11+00:00 https://www.lmi.no/2025/11/28/helseministeren-vil-at-sykepleiere-skal-kunne-skrive-ut-medisiner/ 2025-11-28T10:41:03+00:00 https://www.lmi.no/2025/11/28/franske-myndigheter-gjennomforte-razzia-mot-sanofis-hovedkontor/ 2025-11-28T10:42:22+00:00 https://www.lmi.no/2025/11/28/gullfeber-i-adc-markedet-hver-ny-godkjenning-er-et-nytt-marked/ 2025-11-28T10:43:04+00:00 https://www.lmi.no/2025/11/28/atte-selskaper-plukket-ut-til-akseleratorprogram/ 2025-11-28T10:43:51+00:00 https://www.lmi.no/2025/11/28/lmi-reagerer-kraftig-pa-saernorsk-reklameregel/ 2025-11-28T10:45:03+00:00 https://www.lmi.no/2025/12/01/studie-blodtrykksmedisin-kobles-til-kreft/ 2025-12-01T10:39:09+00:00 https://www.lmi.no/2025/12/01/kjente-seg-nedfor-og-trist-det-har-definitivt-hjelpt/ 2025-12-01T10:41:07+00:00 https://www.lmi.no/2025/12/01/vanlege-medisinar-kan-gjere-hovudpine-verre/ 2025-12-01T10:42:32+00:00 https://www.lmi.no/2025/12/01/johnson-johnson-nar-en-markedsverdi-pa-500-milliarder-dollar/ 2025-12-01T10:43:24+00:00 https://www.lmi.no/2025/12/01/photocure-fikk-kreftforeningens-innovasjonspris/ 2025-12-01T10:44:25+00:00 https://www.lmi.no/2025/12/01/eisai-og-biogen-soker-om-ny-variant-av-alzheimer-middel-i-japan/ 2025-12-01T10:45:36+00:00 https://www.lmi.no/2025/12/01/medwatch-erfarer-nye-oppsigelser-i-pfizer-norge/ 2025-12-01T10:46:36+00:00 https://www.lmi.no/2025/12/01/eu-sier-ja-til-scemblix-i-forstelinje-kan-oke-sjansen-for-behandlingsfri-remisjon/ 2025-12-01T10:47:21+00:00 https://www.lmi.no/2025/12/01/zelluna-henter-finansdirektor-fra-egne-rekker/ 2025-12-01T10:48:03+00:00 https://www.lmi.no/2025/12/01/fredrik-advarer-mot-slankesproyter-det-har-odelagt-livet-mitt/ 2025-12-01T10:49:07+00:00 https://www.lmi.no/2025/12/01/norske-interesser-i-et-endret-europa/ 2025-12-01T10:50:28+00:00 https://www.lmi.no/2025/12/01/uke-49-pa-helsefeltet-legemiddelrapport-ki-seminar-og-budsjettopplop/ 2025-12-01T10:51:45+00:00 https://www.lmi.no/2025/12/01/norske-klinikere-derfor-bor-leger-delta-i-industriens-advisory-boards/ 2025-12-01T10:52:29+00:00 https://www.lmi.no/2025/12/01/amgen-norge-henter-radgiver-fra-kruse-larsen/ 2025-12-01T10:53:13+00:00 https://www.lmi.no/2025/12/01/sykehusinnkjop-bytter-innkjopsverktoy/ 2025-12-01T11:15:15+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Datasystem_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Datasystem_AdobeStock-scaled.jpeg https://www.lmi.no/2025/12/01/photocure-fikk-kreftforeningens-innovasjonspris-2/ 2025-12-01T11:25:39+00:00 https://www.lmi.no/wp-content/uploads/2025/12/photocure-jpg.webp https://www.lmi.no/wp-content/uploads/2025/12/photocure-jpg.webp https://www.lmi.no/2025/11/26/myndigheter-og-legemiddelprodusenter-mottes-for-forste-gang-om-beredskap/ 2025-12-01T11:48:48+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Mote-myndigheter-og-legemiddelprodusenter-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/11/Mote-myndigheter-og-legemiddelprodusenter-2025-scaled.jpg https://www.lmi.no/2025/12/02/stortingsrepresentantenes-helseaksjer-satser-pa-kreftforskning-legemiddelfabrikk-og-fedmemedisin/ 2025-12-02T11:15:45+00:00 https://www.lmi.no/2025/12/02/usa-presser-storbritannia-til-a-oke-betalingsviljen-for-legemidler-hva-betyr-det-for-norge/ 2025-12-02T11:16:27+00:00 https://www.lmi.no/2025/12/02/enorm-vaksine-pagang-tror-ikke-vi-har-opplevd-dette-tidligere/ 2025-12-02T11:17:23+00:00 https://www.lmi.no/2025/12/02/oncoinvent-fikk-tegninger-for-181-millioner-aksjer-i-emisjonen/ 2025-12-02T11:18:08+00:00 https://www.lmi.no/2025/12/02/patrick-59-fikk-sjokk-da-han-tok-slankemedisin-%e2%81%a0-det-var-helt-vilt/ 2025-12-02T11:18:54+00:00 https://www.lmi.no/2025/12/02/nei-beslutning-skapte-forvirring-na-skal-kreftbehandlingen-vurderes-pa-nytt/ 2025-12-02T11:19:43+00:00 https://www.lmi.no/2025/12/02/hun-er-ny-omradedirektor-i-dmp/ 2025-12-02T11:20:30+00:00 https://www.lmi.no/2025/12/02/norsk-selskap-gar-etter-glemt-kreftmal-som-gigantene-ikke-dekker/ 2025-12-02T11:21:12+00:00 https://www.lmi.no/2025/12/02/hevder-koronavaksine-ga-kronisk-utmattelsessyndrom/ 2025-12-02T11:21:55+00:00 https://www.lmi.no/2025/12/02/glp-1-behandling-pa-whos-liste-over-essensielle-legemidler/ 2025-12-02T11:22:51+00:00 https://www.lmi.no/2025/12/02/beslutningsforum-har-ni-saker-pa-listen-i-sitt-desembermote/ 2025-12-02T11:23:36+00:00 https://www.lmi.no/2025/12/02/ny-rapport-stabile-utgifter-til-legemidler/ 2025-12-02T11:52:26+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Bugge-front-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/12/Skjermbilde-2025-12-02-092843.png https://www.lmi.no/2025/12/02/nho-etablerer-ekspertutvalg-for-helse-og-velferdstjenester/ 2025-12-02T14:36:53+00:00 https://www.lmi.no/wp-content/uploads/2025/12/reidar-2024-blid-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/reidar-2024-blid-scaled.jpg https://www.lmi.no/2025/12/03/legemiddelutgiftene-oker-men-prisene-er-ikke-hovedforklaringen/ 2025-12-03T09:40:07+00:00 https://www.lmi.no/2025/12/03/bayer-kan-fa-drahjelp-av-trump-administrasjonen-i-gigantsoksmal/ 2025-12-03T09:40:52+00:00 https://www.lmi.no/2025/12/03/sjokkert-over-wegovy-bruk-blant-nybakte-modre/ 2025-12-03T09:41:47+00:00 https://www.lmi.no/2025/12/03/knut-gunnar-66-dro-ikke-til-legen-for-han-hadde-tisset-blod-i-et-halvt-ar/ 2025-12-03T09:42:55+00:00 https://www.lmi.no/2025/12/03/fikk-astrazeneca-vaksinen-sa-endret-livet-seg-totalt/ 2025-12-03T09:43:44+00:00 https://www.lmi.no/2025/12/03/eu-tar-nytt-steg-mot-bedre-tilgang-til-kritiske-legemidler/ 2025-12-03T09:44:25+00:00 https://www.lmi.no/2025/12/03/hun-blir-ny-leder-for-pfizer-norge/ 2025-12-03T09:45:15+00:00 https://www.lmi.no/2025/12/04/advarer-mot-vanlig-misforstaelse-tenker-ikke-over-det/ 2025-12-04T11:31:39+00:00 https://www.lmi.no/2025/12/04/konkurransetilsynet-fortsetter-vurdering-av-oppkjopet-av-norsk-medisinaldepot/ 2025-12-04T11:34:39+00:00 https://www.lmi.no/2025/12/04/avviser-lavere-klimaambisjoner-etter-spareplan/ 2025-12-04T12:02:20+00:00 https://www.lmi.no/2025/12/04/marianne-feirer-historisk-vaksineseier-mot-staten/ 2025-12-04T12:03:50+00:00 https://www.lmi.no/2025/12/04/vaksine-ekspert-her-er-det-mye-vi-ikke-vet/ 2025-12-04T12:04:50+00:00 https://www.lmi.no/2025/12/04/ny-pfizer-sjef-bekrefter-nedbemanning-og-endringer-i-norge/ 2025-12-04T12:05:39+00:00 https://www.lmi.no/2025/12/04/actithera-henter-erfaren-radiofarmasiressurs-som-medisinsk-direktor/ 2025-12-04T12:06:28+00:00 https://www.lmi.no/2025/12/04/lmi-i-dagens-medisin-275-000-kronerssporsmalet/ 2025-12-04T13:11:37+00:00 https://www.lmi.no/wp-content/uploads/2025/12/DM_275kronersporsmalet.png https://www.lmi.no/wp-content/uploads/2025/12/DM_275kronersporsmalet.png https://www.lmi.no/2025/12/05/onsker-rekvisisjonsrett-for-flere-vaksiner/ 2025-12-05T10:15:08+00:00 https://www.lmi.no/2025/12/05/erlend-svardal-boe-h-spor-helseministeren-om-terskelverdi-strategi/ 2025-12-05T10:28:39+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Jan-Christian-Vestre-og-Erlend-Svardal-Boe.png https://www.lmi.no/wp-content/uploads/2025/12/Erlend-Svardal-Boe_Foto-Stortinget_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Jan-Christian-Vestre_Foto-Stortinget_crop-scaled.jpg https://www.lmi.no/2025/12/05/sanofi-har-fullfort-oppkjopet-av-britisk-selskap/ 2025-12-05T10:33:10+00:00 https://www.lmi.no/2025/12/05/novartis-vekstmotor-gar-for-fullt-men-ikke-i-norge/ 2025-12-05T10:34:01+00:00 https://www.lmi.no/2025/12/05/leddgikt-dette-vil-pasienter-og-fagfolk-vite-mer-om/ 2025-12-05T10:39:11+00:00 https://www.lmi.no/2025/12/05/det-finnes-en-medisin-som-kan-gi-meg-haret-tilbake/ 2025-12-05T10:43:00+00:00 https://www.lmi.no/2025/12/05/uio-professor-henter-12-millioner-til-nordisk-legemiddelberedskapsprosjekt/ 2025-12-05T10:45:54+00:00 https://www.lmi.no/2025/12/05/psoriasis-symptomene-du-skal-ta-pa-alvor/ 2025-12-05T10:51:02+00:00 https://www.lmi.no/2025/12/05/dmp-har-konkludert-om-rsv/ 2025-12-05T10:52:06+00:00 https://www.lmi.no/2025/12/05/slar-alarm-om-okt-bruk-av-tramadol-i-norge-store-forskjeller-mellom-norge-og-nabolandene/ 2025-12-05T10:54:00+00:00 https://www.lmi.no/2025/12/05/ble-me-syk-etter-koronavaksine-pasientskadenemnda-domt-til-a-betale-erstatning/ 2025-12-05T10:56:42+00:00 https://www.lmi.no/2025/12/05/ge-healthcare-far-vei-agder-setter-av-100-millioner/ 2025-12-05T10:57:31+00:00 https://www.lmi.no/2025/12/05/industrien-vil-nesten-doble-terskelverdien-advarer-om-at-norge-kan-havne-bakerst-i-koen-for-nye-medisiner/ 2025-12-05T10:59:47+00:00 https://www.lmi.no/2025/12/05/ema-direktor-advarer-ettersporselen-etter-fedmemedisin-kan-lope-lopsk/ 2025-12-05T11:01:00+00:00 https://www.lmi.no/2025/12/05/legemiddelfeil-hvem-passer-pa-deg-nar-alle-har-ansvar/ 2025-12-05T11:03:11+00:00 https://www.lmi.no/2025/12/05/lanserer-en-pilot-for-hurtiglop-for-godkjenning-av-kliniske-studier-i-eu-eos/ 2025-12-05T11:12:07+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Kliniske-studier_hurtiglop-godkjenning-blury-scaled.png https://www.lmi.no/wp-content/uploads/2025/12/Kliniske-studier_hurtiglop-godkjenning-blury-scaled.png https://www.lmi.no/wp-content/uploads/2025/01/image.jpeg https://www.lmi.no/wp-content/uploads/2024/09/Ina-Dahlsveen-crop.png https://www.lmi.no/wp-content/uploads/2022/09/Signe-Oien-Fretland-HIGHRES-scaled.jpg https://www.lmi.no/2025/12/05/omfattende-off-label-bruk-skaper-utfordringer/ 2025-12-05T11:52:52+00:00 https://www.lmi.no/wp-content/uploads/2025/12/veronika-i-medwatch-forside.png https://www.lmi.no/wp-content/uploads/2025/12/Veronika-i-medwatch-ny.png https://www.lmi.no/2025/12/08/lmis-horingssvar-pa-tilgjengeliggjoring-av-helsedata/ 2025-12-09T08:19:16+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2025/12/09/amgen-norge-feirer-25-ar/ 2025-12-09T08:47:13+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Amgen_Jorgen-og-Kjersti-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Amgen_Jorgen-og-Kjersti-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/05/Tore-von-Wurden-ny-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Amgen_Gruppebilde-2025-scaled.jpeg https://www.lmi.no/2025/12/09/slik-tok-kina-kontroll-over-vestlig-medisinproduksjon-spilte-ikke-etter-de-samme-reglene-som-andre/ 2025-12-09T09:09:03+00:00 https://www.lmi.no/2025/12/09/flere-legemiddelselskaper-har-inngatt-avtaler-med-trump-far-ny-frist/ 2025-12-09T09:10:35+00:00 https://www.lmi.no/2025/12/09/jaypirca-minst-like-effektiv-som-imbruvica-i-ny-kll-studie/ 2025-12-09T09:11:48+00:00 https://www.lmi.no/2025/12/09/norske-pasienter-far-na-tilgang-pa-rekordtid/ 2025-12-09T09:12:44+00:00 https://www.lmi.no/2025/12/09/mounjaro-far-plass-pa-kinas-nasjonale-refusjonsliste/ 2025-12-09T09:13:37+00:00 https://www.lmi.no/2025/12/09/jubeldag-for-pasienter-med-alvorlig-hartap-og-benmargskreft-ja-til-bade-litfulo-og-blenrep/ 2025-12-09T09:38:27+00:00 https://www.lmi.no/2025/12/09/beslutningsforum-sier-ja-til-flere-nye-behandlinger/ 2025-12-09T09:39:36+00:00 https://www.lmi.no/2025/12/09/gsk-om-blenrep-ja-saken-har-loftet-viktige-problemstillinger/ 2025-12-09T09:40:28+00:00 https://www.lmi.no/2025/12/09/circio-skal-hente-50-millioner-kroner-sikter-mot-kliniske-studier-i-2027/ 2025-12-09T09:41:24+00:00 https://www.lmi.no/2025/12/09/blir-beskrevet-som-magisk-na-oker-bruken/ 2025-12-09T09:42:16+00:00 https://www.lmi.no/2025/12/09/gjor-kjempeinvestering-i-dansk-biotek/ 2025-12-09T09:43:19+00:00 https://www.lmi.no/2025/12/09/dmp-har-landet-anbefaling-om-alternativkostnad-krevende/ 2025-12-09T09:44:11+00:00 https://www.lmi.no/2025/12/09/programmet-klart-for-norway-life-science-2026/ 2025-12-09T10:27:34+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Norway-Life-Science-2026-front-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/11/Norway-Life-Science-2026-front-kopi.jpg https://www.lmi.no/2025/12/09/link-medical-styrker-laget/ 2025-12-09T10:43:06+00:00 https://www.lmi.no/2025/12/11/stor-interesse-for-vaksine-som-gir-lavere-risiko-for-demens/ 2025-12-11T09:47:56+00:00 https://www.lmi.no/2025/12/11/udokumenterte-pastander-om-covid-vaksiner-truer-bade-folkehelsen-og-tilliten-til-institusjoner/ 2025-12-11T09:49:07+00:00 https://www.lmi.no/2025/12/11/oppdagelser-om-immunsystemet-kan-gi-gjennombrudd-i-behandling-av-kreft-og-betennelsessykdommer/ 2025-12-11T09:50:46+00:00 https://www.lmi.no/2025/12/11/jaypirca-slar-kjemoimmunterapi-i-forstelinje-kll-kan-bli-ny-standard/ 2025-12-11T09:51:43+00:00 https://www.lmi.no/2025/12/11/legger-enda-et-vekttap-legemiddel-til-pipelinen/ 2025-12-11T09:52:33+00:00 https://www.lmi.no/2025/12/11/far-nei-til-livsviktig-medisin-uforstaelig/ 2025-12-11T09:54:45+00:00 https://www.lmi.no/2025/12/11/gir-langvarig-sykdomskontroll-ved-itp-halverer-risikoen-for-behandlingssvikt/ 2025-12-11T09:55:36+00:00 https://www.lmi.no/2025/12/11/ge-healthcare-karet-til-arets-bedrift-i-agder/ 2025-12-11T09:56:46+00:00 https://www.lmi.no/2025/12/11/eu-lander-legemiddelreform/ 2025-12-11T09:57:44+00:00 https://www.lmi.no/2025/12/11/hoyre-krever-svar-om-norsk-prisstrategi-for-legemidler/ 2025-12-11T09:59:40+00:00 https://www.lmi.no/2025/12/11/alopecia-pasientene-jubler-for-litfulo-ja-en-julegave/ 2025-12-11T10:00:31+00:00 https://www.lmi.no/2025/12/11/vestre-om-toll-pa-legemidler-vi-tar-signalene-fra-trump-pa-alvor/ 2025-12-11T10:01:24+00:00 https://www.lmi.no/2025/12/11/toll-pa-legemidler-det-holder-ikke-a-sitte-stille-i-baten/ 2025-12-11T10:02:15+00:00 https://www.lmi.no/2025/12/11/mener-norsk-radiofarmasi-kan-betjene-europa/ 2025-12-11T10:03:07+00:00 https://www.lmi.no/2025/12/11/vestre-vil-ikke-kopiere-britenes-prisgrep-pa-legemidler-vi-sonderer/ 2025-12-11T10:03:58+00:00 https://www.lmi.no/2025/12/11/ett-av-de-beste-resultatene-vi-har-sett-ved-tilbakefall-av-myelomatose/ 2025-12-11T10:04:48+00:00 https://www.lmi.no/2025/12/11/novartis-med-nytt-partnerskap-skal-bruke-kunstig-intelligens-for-a-finne-allergikandidater/ 2025-12-11T10:11:43+00:00 https://www.lmi.no/2025/12/11/faerre-overleger-forsker-det-burde-bekymre-oss-mer-enn-det-gjor/ 2025-12-11T10:13:00+00:00 https://www.lmi.no/2025/12/11/ny-teknologi-lager-car-t-direkte-i-kroppen-de-forste-pasientene-viser-dype-responser/ 2025-12-11T10:14:33+00:00 https://www.lmi.no/2025/12/11/lmi-i-dagens-medisin-det-holder-ikke-a-sitte-stille-i-baten/ 2025-12-11T10:15:25+00:00 https://www.lmi.no/wp-content/uploads/2025/12/DM-111225.png https://www.lmi.no/wp-content/uploads/2025/12/DM-111225.png https://www.lmi.no/2025/12/11/fda-varsler-ny-sikkerhetsvurdering-av-rsv-behandlinger-fra-sanofi-astra-zeneca-og-msd/ 2025-12-11T10:15:52+00:00 https://www.lmi.no/2025/12/12/reddet-atte-ars-databeskyttelse-men-industrien-mener-legemiddelpakken-fortsatt-svekker-innovasjonen/ 2025-12-12T09:57:36+00:00 https://www.lmi.no/2025/12/12/vaksinerekord-for-influensavaksinen/ 2025-12-12T09:58:28+00:00 https://www.lmi.no/2025/12/12/kritiserer-svak-metodevurdering-til-tross-for-litfulo-ja-i-beslutningsforum/ 2025-12-12T09:59:22+00:00 https://www.lmi.no/2025/12/12/dmp-slar-tilbake-mot-litfulo-kritikk-svaert-mangelfullt-dokumentert-fra-firma/ 2025-12-12T10:00:10+00:00 https://www.lmi.no/2025/12/12/pfizer-norge-ut-mot-saksbehandling-tidsbruken-burde-vekke-oppsikt/ 2025-12-12T10:00:51+00:00 https://www.lmi.no/2025/12/12/eli-lilly-leverer-positive-resultater-fra-studie-pa-neste-generasjons-fedmemiddel/ 2025-12-12T10:01:36+00:00 https://www.lmi.no/2025/12/12/ny-brystkreftpille-reduserer-risiko-for-tilbakefall-med-30-prosent/ 2025-12-12T10:02:27+00:00 https://www.lmi.no/2025/12/12/emma-cerrone-tar-over-roret-i-msd-norge-og-finland/ 2025-12-12T10:03:41+00:00 https://www.lmi.no/2025/12/12/msd-norge-fortsetter-som-egen-organisasjon/ 2025-12-12T10:04:26+00:00 https://www.lmi.no/2025/12/12/pfizer-kutter-over-200-stillinger-i-sveits/ 2025-12-12T10:05:06+00:00 https://www.lmi.no/2025/12/12/amerikansk-storbank-ser-stort-potensial-i-eli-lillys-nye-fedmemiddel/ 2025-12-12T10:06:04+00:00 https://www.lmi.no/2025/12/12/trodelvy-skuffer-i-hr-brystkreft-ingen-gevinst-som-forste-behandling-etter-endokrin-terapi/ 2025-12-12T10:06:51+00:00 https://www.lmi.no/2025/12/12/her-er-listen-over-helse-norges-mektigste/ 2025-12-12T10:07:40+00:00 https://www.lmi.no/2025/12/15/zelluna-klar-for-forste-test-av-ny-kreftbehandling-pa-mennesker/ 2025-12-15T14:06:41+00:00 https://www.lmi.no/2025/12/15/ingen-overlevelsegevinst-med-palbociclib-nye-data-viser-klare-forskjeller-mellom-cdk4-6-hemmere/ 2025-12-15T14:07:36+00:00 https://www.lmi.no/2025/12/15/legemiddelfirma-kurser-helsepersonell-i-osteoporose-diagnostikk/ 2025-12-16T08:21:36+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Osteoporose-scan_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Osteoporose-scan_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/May-Britt-Stenbro-2.jpg https://www.lmi.no/wp-content/uploads/2025/12/Merete-Finjarn-2_Foto-privat.jpg https://www.lmi.no/wp-content/uploads/2025/12/Leif-Rune-Skymoen_portrett_edited.jpg https://www.lmi.no/2025/12/16/sart-a-bruke-parykk-som-ung-gutt/ 2025-12-16T09:52:06+00:00 https://www.lmi.no/2025/12/16/norges-ferskeste-radiofarmasiselskap-vil-gjore-norge-mer-attraktivt-for-kliniske-studier/ 2025-12-16T09:52:53+00:00 https://www.lmi.no/2025/12/16/hod-vil-overfore-vaksineansvar-til-private-grossister/ 2025-12-16T09:54:11+00:00 https://www.lmi.no/2025/12/16/eu-komite-anbefaler-a-godkjenne-syv-nye-legemidler/ 2025-12-16T09:54:59+00:00 https://www.lmi.no/2025/12/16/tukysa-forlenger-progresjonsfri-overlevelse-med-over-atte-maneder/ 2025-12-16T09:56:57+00:00 https://www.lmi.no/2025/12/16/konkurransetilsynet-norgesgruppen-far-kjope-vitusapotek/ 2025-12-16T09:57:51+00:00 https://www.lmi.no/2025/12/16/lars-vet-ikke-om-han-far-tak-i-medisin-snakk-om-liv-og-dod/ 2025-12-16T09:58:36+00:00 https://www.lmi.no/2025/12/16/vestre-vil-apne-dorene-for-flere-private/ 2025-12-16T09:59:18+00:00 https://www.lmi.no/2025/12/16/flytter-ansvaret-for-finansiering-av-rs-medisiner/ 2025-12-16T10:00:09+00:00 https://www.lmi.no/2025/12/16/rootwelt-og-spreng-takker-av-etter-mer-enn-to-ar-i-beslutningsforum-ledelsen/ 2025-12-16T10:01:20+00:00 https://www.lmi.no/2025/12/16/sobi-kjoper-biotek-selskap-for-15-milliarder-kroner/ 2025-12-16T10:02:05+00:00 https://www.lmi.no/2025/12/16/svensk-selskap-forst-ut-fda-godkjenner-hjemmebehandling-mot-depresjon/ 2025-12-16T10:03:07+00:00 https://www.lmi.no/2025/12/16/legemiddelgiganter-unngar-tollsjokk/ 2025-12-16T10:03:58+00:00 https://www.lmi.no/2025/12/16/dmp-sier-nei-til-hjertemedisin-pa-nytt/ 2025-12-16T10:05:34+00:00 https://www.lmi.no/2025/12/16/han-blir-ny-myndighetskontakt-for-novo-nordisk-i-norge/ 2025-12-16T10:12:38+00:00 https://www.lmi.no/2025/12/16/fda-planlegger-black-box-advarsel-pa-covid-19-vaksiner/ 2025-12-16T10:13:32+00:00 https://www.lmi.no/2025/12/16/frp-utfordrer-regjeringen-pa-betalingsvillighet-for-legemidler/ 2025-12-16T11:38:59+00:00 https://www.lmi.no/wp-content/uploads/2025/12/JuliaBrannstrom_JanChristianVestre.jpg https://www.lmi.no/wp-content/uploads/2025/12/JuliaBrannstrom_JanChristianVestre.jpg https://www.lmi.no/2025/12/16/eus-revisjon-av-legemiddellovgivningen/ 2025-12-16T11:49:53+00:00 https://www.lmi.no/wp-content/uploads/2023/11/EU-pharma-strategy_legislation_Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/EU-pharma-strategy_legislation_Adobe-Stock-16_9.jpeg https://www.lmi.no/2025/12/12/pa-tide-med-litt-egenomsorg/ 2025-12-16T18:33:36+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Kviser_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Kviser_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Reseptfritt-legemiddel-logo.png https://www.lmi.no/2025/12/12/hvor-er-det-tryggest-a-handle-reseptfrie-legemidler/ 2025-12-16T18:34:20+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Apotek-kunde_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Apotek-kunde_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Trygge-legemidler-symbol.png https://www.lmi.no/2025/12/12/folk-bor-fa-mer-informasjon-om-egenomsorg/ 2025-12-16T18:35:57+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Kristian-Jong-Hoines-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Kristian-Jong-Hoines-scaled.jpeg https://www.lmi.no/2025/12/12/apotekene-hjelper-deg-gjerne-med-egenomsorg/ 2025-12-16T18:37:56+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Hanne-Andresen_Apotekforeningen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Hanne-Andresen_Apotekforeningen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Sigurd-Hoye-scaled.jpg https://www.lmi.no/2025/12/17/forskningsradet-utlyser-naerings-ph-d/ 2025-12-17T09:45:36+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Siri-B_Photo-credit-Thomas-Brun-NTB-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Siri-B_Photo-credit-Thomas-Brun-NTB-1-scaled.jpg https://www.lmi.no/2025/12/17/pfizer-skuffer-med-nye-inntektsprognoser/ 2025-12-17T10:33:53+00:00 https://www.lmi.no/2025/12/17/deler-ut-over-en-kvart-milliard-til-helseinnovasjon/ 2025-12-17T10:35:36+00:00 https://www.lmi.no/2025/12/17/legemidlet-ble-innfort-men-forst-etter-to-systemflaskehalser/ 2025-12-17T10:38:31+00:00 https://www.lmi.no/2025/12/17/sanofi-inngar-alzheimer-avtale-verdt-over-ti-milliarder-kroner/ 2025-12-17T10:39:58+00:00 https://www.lmi.no/2025/12/17/hyller-ny-kreftbehandling-medisinsk-revolusjon/ 2025-12-17T10:41:57+00:00 https://www.lmi.no/2025/12/17/inviterte-til-rundebordsmote-om-helsedata/ 2025-12-17T11:29:54+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Rundebordsmote_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Rundebordsmote_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/09/Ina-Dahlsveen-crop-1.png https://www.lmi.no/wp-content/uploads/2025/12/Monica-Larsen_crop.jpg https://www.lmi.no/2025/12/12/egenomsorg-sparer-samfunnet-for-store-summer/ 2025-12-17T14:53:09+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Skjermbilde-fra-AESGP-rapporten-om-selfcare_figur-3.png https://www.lmi.no/wp-content/uploads/2025/12/Skjermbilde-fra-AESGP-rapporten-om-selfcare_figur-3.png https://www.lmi.no/wp-content/uploads/2025/04/Legekontor-helsedata-Adobe-Stock-scaled.jpeg https://www.lmi.no/2025/12/17/storre-synlighet-for-reseptfrie-legemidler-og-egenomsorg/ 2025-12-17T14:53:19+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Skjermbilde-fra-AESGP-rapporten-om-selfcare_figur-3.png https://www.lmi.no/wp-content/uploads/2025/12/egenomsorg-skjermbilde-4.png https://www.lmi.no/wp-content/uploads/2025/12/Egenomsorg-skjermbilde-1.png https://www.lmi.no/wp-content/uploads/2025/12/Egenomsorg-skjermbilde-2.png https://www.lmi.no/wp-content/uploads/2025/12/Egenomsorg-skjermbilde-3.png https://www.lmi.no/2025/12/17/presentasjoner-fra-drug-safety-forum-17-november-2025/ 2025-12-17T15:34:09+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Drug-Safety-Forum-2024-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/11/Drug-Safety-Forum-2024-scaled.jpg https://www.lmi.no/2025/12/19/mange-nominasjoner-til-komiteer-og-adboards/ 2025-12-19T08:36:07+00:00 https://www.lmi.no/wp-content/uploads/2025/12/KOmite-nominering-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/KOmite-nominering-scaled.jpg https://www.lmi.no/2025/12/19/lmi-i-dialogforum-med-hod-og-nfd/ 2025-12-19T09:49:38+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Dialogforum-NFD-og-HOD-181225-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/Dialogforum-NFD-og-HOD-181225-scaled.jpg https://www.lmi.no/2025/12/19/fleire-og-fleire-vaksinerer-seg-mot-vasskoppar/ 2025-12-19T11:39:05+00:00 https://www.lmi.no/2025/12/19/eu-anbefaler-ja-til-trippel-dose-med-wegovy-kan-ledsages-av-flere-bivirkninger/ 2025-12-19T11:39:54+00:00 https://www.lmi.no/2025/12/19/astra-zeneca-norge-styrer-mot-kraftig-veksthopp/ 2025-12-19T11:41:21+00:00 https://www.lmi.no/2025/12/19/nykode-foreslar-ny-styreleder-og-nytt-styremedlem/ 2025-12-19T11:42:03+00:00 https://www.lmi.no/2025/12/19/fhi-det-er-feil-at-den-eine-vaksinen-er-sterkare-enn-den-andre/ 2025-12-19T11:43:10+00:00 https://www.lmi.no/2025/12/19/eli-lilly-far-hurtigbehandling-i-ny-fedmetablett-soknad/ 2025-12-19T11:44:35+00:00 https://www.lmi.no/2025/12/19/dmp-og-universitetet-i-oslo-far-20-millioner-til-beredskapsprosjekt/ 2025-12-19T11:45:17+00:00 https://www.lmi.no/2025/12/19/bms-landssjef-i-norge-gar-av/ 2025-12-19T11:46:00+00:00 https://www.lmi.no/2025/12/19/naeringen-slar-tilbake-mot-regjeringens-eksportoptimisme/ 2025-12-19T11:46:45+00:00 https://www.lmi.no/2025/12/19/eli-lillys-nye-fedmepille-spas-salg-pa-et-tosifret-milliardbelop-det-forste-aret/ 2025-12-19T11:47:23+00:00 https://www.lmi.no/2025/12/19/eus-biotech-act-skal-gjore-europa-mer-innovativ-og-konkurransedyktig/ 2025-12-19T13:54:08+00:00 https://www.lmi.no/wp-content/uploads/2025/12/EU-lov_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/EU-lov_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/01/Ina-Kathrine-Dahlsveen-5755-scaled.jpg https://www.lmi.no/2025/12/22/tydelig-virus-skille-mellom-ost-og-vest/ 2025-12-22T09:41:30+00:00 https://www.lmi.no/2025/12/22/ny-medisin-bremser-alvorlige-sykdommer-hoppende-gener-er-nokkelen-til-superkuren/ 2025-12-22T09:43:22+00:00 https://www.lmi.no/2025/12/22/salget-av-reseptfrie-legemidler-skyter-i-vaeret-i-desember/ 2025-12-22T09:44:18+00:00 https://www.lmi.no/2025/12/22/abelia-sjef-om-norsk-forskning-vare-nordiske-naboer-himler-med-oynene/ 2025-12-22T09:46:17+00:00 https://www.lmi.no/2025/12/22/ny-alzheimer-medisin-far-nei-i-danmark-kostnadskritikk-i-sverige-uavklart-i-norge/ 2025-12-22T09:47:00+00:00 https://www.lmi.no/2025/12/22/trump-inngar-prisavtale-med-ni-legemiddelgiganter-roche-sjef-varsler-dyrere-medisiner-i-europa/ 2025-12-22T09:47:45+00:00 https://www.lmi.no/2025/12/22/mener-disse-seks-grepene-kan-snu-norsk-helsenaering/ 2025-12-22T09:48:29+00:00 https://www.lmi.no/2025/12/22/krass-og-usaklig-men-ikke-inhabil/ 2025-12-22T09:50:24+00:00 https://www.lmi.no/2025/12/22/regjeringen-avlopsdirektivet-skal-implementeres-i-norge/ 2025-12-22T11:05:44+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Urban-waste-water-treatment_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Urban-waste-water-treatment_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/01/Anne-Margrethe-Hausken-Nordberg-6025-scaled.jpg https://www.lmi.no/2025/12/22/digitalis-tar-juleferie-4/ 2025-12-22T11:38:38+00:00 https://www.lmi.no/wp-content/uploads/2024/12/God_jul_kopi_med_tekst-1734611430.jpg https://www.lmi.no/wp-content/uploads/2024/12/God_jul_kopi_med_tekst-1734611430.jpg https://www.lmi.no/2026/01/02/68120/ 2026-01-02T09:06:14+00:00 https://www.lmi.no/2026/01/02/immunterapi-ga-grete-livet-tilbake/ 2026-01-02T09:13:11+00:00 https://www.lmi.no/2026/01/02/ragnhild-fra-otta-er-stortingsrepresentant-og-sitter-i-helse-og-omsorgskomiteen/ 2026-01-02T09:23:56+00:00 https://www.lmi.no/2026/01/02/verdens-parkinson-tilfeller-trolig-fordoblet-innen-2050/ 2026-01-02T09:34:57+00:00 https://www.lmi.no/2026/01/02/novo-nordisk-blant-de-storste-europeiske-taperne-i-2025/ 2026-01-02T09:39:30+00:00 https://www.lmi.no/2026/01/02/eli-lilly-og-novo-nordisk-kutter-prisene-pa-fedmemidler-i-kina/ 2026-01-02T09:41:39+00:00 https://www.lmi.no/2026/01/02/ketamin-og-esketamin-fores-opp-pa-narkotikalisten/ 2026-01-02T09:47:19+00:00 https://www.lmi.no/2026/01/02/ottersen-om-eus-nye-regelverk-for-legemidler-kan-gi-bedre-tilgang-i-sma-markeder/ 2026-01-02T09:48:56+00:00 https://www.lmi.no/2026/01/02/sanofi-kjoper-vaksineselskap-for-22-milliarder-kroner/ 2026-01-02T10:11:19+00:00 https://www.lmi.no/2026/01/02/navamedic-lanserer-grete-roede-samarbeid/ 2026-01-02T10:13:13+00:00 https://www.lmi.no/2026/01/02/helt-ny-roseacea-behandling-hylles/ 2026-01-02T10:20:35+00:00 https://www.lmi.no/2026/01/02/john-arne-rottingen-tilliten-til-forskning-er-svekket-etter-pandemien/ 2026-01-02T10:57:48+00:00 https://www.lmi.no/2026/01/02/lmi-slar-tilbake-mot-kritikken-det-er-kjempeviktig/ 2026-01-02T10:58:24+00:00 https://www.lmi.no/2026/01/02/forskningsradet-gir-35-millioner-til-legemiddelforskning/ 2026-01-02T11:02:07+00:00 https://www.lmi.no/2026/01/02/bra-for-mor-men-barna-fikk-femdoblet-forekomst-av-allergi/ 2026-01-02T11:21:17+00:00 https://www.lmi.no/2026/01/02/astra-zeneca-blar-opp-over-20-milliarder-kroner-for-kinesisk-kreftkandidat/ 2026-01-02T11:26:46+00:00 https://www.lmi.no/2026/01/05/legemiddelselskaper-trosser-trumps-politikk-oker-prisene-pa-over-350-legemidler-i-usa/ 2026-01-05T10:02:16+00:00 https://www.lmi.no/2026/01/05/eksplosiv-melatoninbruk-blant-unge-eksperter-advarer/ 2026-01-05T10:03:02+00:00 https://www.lmi.no/2026/01/05/abbvie-kjoper-kreftkandidat-fra-kinesiske-zelgen-for-en-milliard-kroner/ 2026-01-05T10:03:44+00:00 https://www.lmi.no/2026/01/05/kjonnssykdommen-er-pa-fremmarsj-na-kommer-nye-medisiner/ 2026-01-05T10:04:57+00:00 https://www.lmi.no/2026/01/05/definisjonen-av-tettsted-blir-viktig-for-omstridt-eu-direktiv-vi-er-blitt-lyttet-til-sier-ks-lederen/ 2026-01-05T10:06:03+00:00 https://www.lmi.no/2026/01/05/forskere-kan-ha-funnet-mate-a-reversere-alzheimers/ 2026-01-05T10:06:42+00:00 https://www.lmi.no/2026/01/05/vil-avdekke-prostatakreft-med-en-enkel-blodprove/ 2026-01-05T10:07:27+00:00 https://www.lmi.no/2026/01/05/storbank-ser-gode-muligheter-i-helse-og-legemiddelaksjer/ 2026-01-05T10:08:14+00:00 https://www.lmi.no/2026/01/05/disse-lovendringene-pa-helseomradet-bor-du-vite-om-i-2026/ 2026-01-05T10:08:55+00:00 https://www.lmi.no/2026/01/05/tv-2-slar-tilbake-mot-kritikken-det-er-kjempeviktig/ 2026-01-05T10:54:30+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Tv2-saken-verdi-kopi1-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Tv2-saken-verdi-kopi1-scaled.jpg https://www.lmi.no/2026/01/06/vil-ikke-justere-alternativkostnaden-lmi-krever-politisk-handling/ 2026-01-06T11:17:18+00:00 https://www.lmi.no/2026/01/06/lmi-advarer-mot-a-vente-med-justering-av-alternativkostnaden/ 2026-01-06T11:18:05+00:00 https://www.lmi.no/2026/01/06/anbefaler-ingen-midlertidig-endring-av-alternativkostnaden-ikke-tilstrekkelig-grunnlag/ 2026-01-06T11:18:48+00:00 https://www.lmi.no/2026/01/06/hoyre-topp-med-bredside-etter-anbefaling-regjeringen-har-ingen-strategi/ 2026-01-06T11:19:50+00:00 https://www.lmi.no/2026/01/06/forskere-knytter-utbredt-virus-til-blaerekreft/ 2026-01-06T11:20:46+00:00 https://www.lmi.no/2026/01/06/lanserer-fedmepille-med-rabatt/ 2026-01-06T11:21:43+00:00 https://www.lmi.no/2026/01/06/varslet-habilitets-opprydning-fortsatt-ikke-pa-plass/ 2026-01-06T11:22:49+00:00 https://www.lmi.no/2026/01/06/sa-mye-kostet-habiltetsrapporten/ 2026-01-06T11:23:31+00:00 https://www.lmi.no/2026/01/06/alternativkostnaden-blir-ikke-endret-na-hjerteratt/ 2026-01-06T11:24:18+00:00 https://www.lmi.no/2026/01/06/vil-ikke-justere-alternativkostnaden-lmi-krever-politisk-handling-2/ 2026-01-06T12:03:36+00:00 https://www.lmi.no/wp-content/uploads/2026/01/front-digi-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Medieklipp_alternativkostnad060126.jpg https://www.lmi.no/2026/01/07/astrazeneca-pa-scenen-under-nhos-arskonferanse/ 2026-01-07T14:40:57+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Front-NHO-digi-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Front-NHO-digi-kopi-scaled.jpg https://www.lmi.no/2026/01/07/dmp-leder-eu-prosjekt-om-baerekraftig-lagerforvaltning-av-legemidler/ 2026-01-07T14:47:50+00:00 https://www.lmi.no/wp-content/uploads/2026/01/EU-og-legemidler-AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2026/01/EU-og-legemidler-AdobeStock-scaled.jpeg https://www.lmi.no/2026/01/08/usa-godkjente-faerre-nye-legemidler-etter-turbulent-ar-i-fda/ 2026-01-08T09:50:13+00:00 https://www.lmi.no/2026/01/08/artbio-henter-biotekveteran-til-lederrolle/ 2026-01-08T09:51:00+00:00 https://www.lmi.no/2026/01/08/sandoz-henter-tidligere-novo-nordisk-profil-til-ny-nordisk-stilling/ 2026-01-08T09:51:52+00:00 https://www.lmi.no/2026/01/08/novo-nordisk-undersoker-nytt-diabeteslegemiddel-i-fase-1-studie/ 2026-01-08T09:53:30+00:00 https://www.lmi.no/2026/01/08/dnb-sjefen-advarer-vi-har-ikke-samme-posisjon-som-for/ 2026-01-08T09:54:10+00:00 https://www.lmi.no/2026/01/08/astrazeneca-topp-om-hvorfor-norge-sakker-akterut-trenger-mer-tempo-og-forutsigbarhet/ 2026-01-08T09:54:52+00:00 https://www.lmi.no/2026/01/08/slankemedisin-brukere-gar-opp-i-vekt-pa-under-to-ar/ 2026-01-08T09:55:36+00:00 https://www.lmi.no/2026/01/08/morten-jurs-er-ny-navamedic-styreleder/ 2026-01-08T09:56:43+00:00 https://www.lmi.no/2026/01/08/han-leder-kinesisk-selskap-i-europa-man-kan-ikke-fa-99-prosent-rabatt-og-forvente-forsyningssikkerhet/ 2026-01-08T09:58:03+00:00 https://www.lmi.no/2026/01/08/hdir-har-avpublisert-kapittel-i-retningslinje-det-er-et-dilemma/ 2026-01-08T09:59:22+00:00 https://www.lmi.no/2026/01/09/jens-torup-ostby-er-ny-sjef-i-bms-norge/ 2026-01-09T11:22:03+00:00 https://www.lmi.no/2026/01/09/viagra-boom-i-norge-i-ar-tok-det-virkelig-av/ 2026-01-09T11:22:47+00:00 https://www.lmi.no/2026/01/09/amgen-kjoper-britiske-dark-blue-therapeutics-for-85-milliarder-kroner/ 2026-01-09T11:23:30+00:00 https://www.lmi.no/2026/01/09/studie-en-type-hodepine-er-mer-utbredt-enn-antatt/ 2026-01-09T11:24:17+00:00 https://www.lmi.no/2026/01/09/astra-zenecas-nordensjef-norge-utnytter-ikke-sine-fortrinn-i-kampen-om-legemiddelinvesteringer/ 2026-01-09T11:25:03+00:00 https://www.lmi.no/2026/01/09/debatt-norge-venter-mens-helse-blir-sikkerhetspolitikk/ 2026-01-09T11:26:19+00:00 https://www.lmi.no/2026/01/09/lytix-henter-61-millioner-gar-inn-i-2026-med-mange-muligheter/ 2026-01-09T11:27:01+00:00 https://www.lmi.no/2026/01/09/kreftforeningen-vi-trenger-et-tydeligere-og-mer-transparent-regelverk-for-habilitet/ 2026-01-09T11:28:03+00:00 https://www.lmi.no/2026/01/12/helsedirektoren-vi-kommer-til-a-matte-prioritere-og-vi-kommer-til-a-matte-dra-ned-aktivitet/ 2026-01-12T11:27:17+00:00 https://www.lmi.no/2026/01/12/slik-ble-oslo-et-kraftsenter-for-radiofarmasi/ 2026-01-12T11:28:08+00:00 https://www.lmi.no/2026/01/12/msd-kan-vaere-pa-vei-mot-legemiddelindustriens-storste-oppkjop-pa-to-ar/ 2026-01-12T11:28:57+00:00 https://www.lmi.no/2026/01/12/adhd-medisiner-hjelper-millioner-av-mennesker-men-virker-ikke-som-vi-trodde-ekspert-er-overrasket/ 2026-01-12T11:30:08+00:00 https://www.lmi.no/2026/01/12/fredrik-54-ble-alvorlig-syk-%e2%81%a0-jeg-kastet-opp-avforing/ 2026-01-12T11:31:00+00:00 https://www.lmi.no/2026/01/12/debatt-legemiddelinnovasjon-er-ingen-landskamp/ 2026-01-12T11:31:56+00:00 https://www.lmi.no/2026/01/12/1-av-10-eldre-kvalifiserer-til-alzheimers-behandling-viser-norsk-studie-som-er-forst-i-verden/ 2026-01-12T11:32:44+00:00 https://www.lmi.no/2026/01/12/fedme-koster-norge-240-milliarder/ 2026-01-12T11:34:10+00:00 https://www.lmi.no/2026/01/12/geopolitikken-pavirker-tilgangen-til-nye-legemidler/ 2026-01-12T11:35:07+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Helselederforum2026_Skymoen.jpg https://www.lmi.no/wp-content/uploads/2026/01/Helselederforum2026_Skymoen.jpg https://www.lmi.no/2026/01/12/en-frisk-befolkning-er-god-beredskap/ 2026-01-12T11:41:06+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Helselederforum2026_paneldiskusjon.jpg https://www.lmi.no/wp-content/uploads/2026/01/Helselederforum2026_paneldiskusjon.jpg https://www.lmi.no/wp-content/uploads/2026/01/Helselederforum2026_Lofthus.jpg https://www.lmi.no/wp-content/uploads/2026/01/Helselederforum2026_Iversen.jpg https://www.lmi.no/2026/01/09/nye-komiteer-og-advisory-boards/ 2026-01-12T12:38:11+00:00 https://www.lmi.no/wp-content/uploads/2025/12/KOmite-nominering-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/12/KOmite-nominering-scaled.jpg https://www.lmi.no/2026/01/13/ny-bms-norge-sjef-markedstilgang-har-blitt-helt-essensielt/ 2026-01-13T10:38:24+00:00 https://www.lmi.no/2026/01/13/reagerer-pa-tv-2-avsloring-dette-ser-ikke-bra-ut/ 2026-01-13T10:39:05+00:00 https://www.lmi.no/2026/01/13/legemiddelprodusenter-varsler-priskamp-i-europa-etter-trump-avtaler/ 2026-01-13T10:39:46+00:00 https://www.lmi.no/2026/01/13/photocure-studie-blalys-cystoskopi-gir-bedre-kreftpavisning/ 2026-01-13T10:40:27+00:00 https://www.lmi.no/2026/01/13/innspill-til-styrekandidater-i-lmi-6/ 2026-01-13T12:46:26+00:00 https://www.lmi.no/wp-content/uploads/2026/01/LMIs-styre-2025_2-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/LMIs-styre-2025_2-scaled.jpg https://www.lmi.no/2026/01/12/debatt-kunstig-intelligens-i-kliniske-verktoy-nar-tilgang-til-fagkilder-gir-darligere-svar/ 2026-01-13T13:04:32+00:00 https://www.lmi.no/2026/01/14/kreftsjefen-pa-ous-om-schjesvold-pastander-det-er-ikke-riktig/ 2026-01-14T09:31:05+00:00 https://www.lmi.no/2026/01/14/helsenaeringen-etter-helsetalen-fine-ord-ma-folges-av-handling/ 2026-01-14T09:32:52+00:00 https://www.lmi.no/2026/01/14/ahus-lykkes-med-kliniske-kreftstudier-schjesvold-etterlyser-endringer-ved-ous/ 2026-01-14T09:36:10+00:00 https://www.lmi.no/2026/01/14/vestre-i-helsetalen-det-gjor-meg-litt-forbanna/ 2026-01-14T09:36:55+00:00 https://www.lmi.no/2026/01/14/forsker-mulig-for-norge-a-knytte-seg-til-eus-tollunion/ 2026-01-14T09:37:41+00:00 https://www.lmi.no/2026/01/14/han-overtar-jobben-med-a-fronte-upopulaere-medisin-avgjorelser/ 2026-01-14T09:38:26+00:00 https://www.lmi.no/2026/01/14/vanskelig-a-na-nasjonale-mal-hvis-samarbeid-med-industrien-gjores-til-et-habilitetsproblem/ 2026-01-14T09:47:45+00:00 https://www.lmi.no/2026/01/14/en-helsereform-loser-ikke-alt/ 2026-01-14T09:48:58+00:00 https://www.lmi.no/2026/01/14/inven2-finansierer-ny-helsenaering-med-exit-gevinster/ 2026-01-14T09:50:04+00:00 https://www.lmi.no/2026/01/14/abbvie-inngar-milliardavtale-om-kinesisk-kreftmedisin/ 2026-01-14T09:50:47+00:00 https://www.lmi.no/2026/01/14/debatt-god-folkehelse-er-en-del-av-totalberedskapen-var/ 2026-01-14T09:51:51+00:00 https://www.lmi.no/2026/01/14/legemiddelindustrien-utfordrer-vestre-pa-verdens-beste-helsetjeneste/ 2026-01-14T10:24:55+00:00 https://www.lmi.no/2026/01/14/vestre-i-sykehustalen-2026-helsenaeringen-var-har-betydelig-potensiale-for-lonnsom-vekst-og-verdiskapende-eksport/ 2026-01-14T10:41:20+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Vestre-sykehustalen-2026.png https://www.lmi.no/wp-content/uploads/2026/01/Sykehustalen-2026_5.png https://www.lmi.no/wp-content/uploads/2026/01/Barbara-Suter_portrett-2-scaled.jpg https://www.lmi.no/2026/01/16/industritopper-positive-til-ambisiose-mal-for-kliniske-studier-i-norge/ 2026-01-16T09:49:21+00:00 https://www.lmi.no/2026/01/16/mange-flere-far-hodepine-av-smertestillende-enn-antatt/ 2026-01-16T09:50:40+00:00 https://www.lmi.no/2026/01/16/promoterer-slankesproyter-paforer-mer-skam-og-stigma/ 2026-01-16T09:51:36+00:00 https://www.lmi.no/2026/01/16/bayer-spar-vekst-comeback-i-2027/ 2026-01-16T09:52:23+00:00 https://www.lmi.no/2026/01/16/abbvie-inngar-avtale-med-trump-lover-100-milliarder-dollar-det-neste-tiaret/ 2026-01-16T09:53:06+00:00 https://www.lmi.no/2026/01/16/sanofis-teizeild-godkjent-i-eu-forste-behandling-som-kan-forsinke-utviklingen-av-diabetes/ 2026-01-16T09:54:25+00:00 https://www.lmi.no/2026/01/16/bayer-ble-i-norge-etter-algeta-oppkjopet-avgjorende/ 2026-01-16T09:55:12+00:00 https://www.lmi.no/2026/01/16/kalte-slankemedisin-en-revolusjon-har-fatt-penger-fra-produsenten/ 2026-01-16T09:55:52+00:00 https://www.lmi.no/2026/01/16/nrk-programleder-har-du-alltid-vaert-sa-tjukk/ 2026-01-16T09:56:47+00:00 https://www.lmi.no/2026/01/16/jobben-starter-nar-pasienten-har-nadd-vektmalet-eller-onsker-a-slutte-med-medisinen/ 2026-01-16T09:57:34+00:00 https://www.lmi.no/2026/01/16/immunterapi-dominerer-i-arets-forste-beslutningsforum/ 2026-01-16T09:58:36+00:00 https://www.lmi.no/2026/01/16/debatt-ingen-justering-av-alternativkostnaden-hva-med-terskelverdien/ 2026-01-16T09:59:49+00:00 https://www.lmi.no/2026/01/16/direktorene-bestiller-faerre-vurderinger-har-gitt-raskere-tilgang-til-nye-metoder/ 2026-01-16T11:54:55+00:00 https://www.lmi.no/2026/01/16/formidling-av-legemiddelinformasjon-ved-hjelp-av-generativ-ki-er-det-trygt/ 2026-01-16T13:07:58+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Chatbot_AI_AdobeStock.jpeg https://www.lmi.no/wp-content/uploads/2022/02/bente-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Chatbot_AI_AdobeStock.jpeg https://www.lmi.no/2026/01/19/milliarddryss-til-dansk-innovasjonshus-apner-for-norske-helseselskaper/ 2026-01-19T10:04:14+00:00 https://www.lmi.no/2026/01/19/ny-studie-tilbakeviser-trumps-paracet-teori/ 2026-01-19T10:06:40+00:00 https://www.lmi.no/2026/01/19/btk-hemmere-var-et-hett-tema-i-2024-na-skal-en-ny-behandling-vurderes/ 2026-01-19T10:08:22+00:00 https://www.lmi.no/2026/01/19/eli-lilly-med-ny-dato-for-godkjenning-av-fedmepille/ 2026-01-19T10:09:12+00:00 https://www.lmi.no/2026/01/19/novartis-styrker-radiofarmasi-posisjonen-med-kina-kjop/ 2026-01-19T10:09:56+00:00 https://www.lmi.no/2026/01/19/eli-lillys-nykommer-presser-novo-nordisk-i-norges-heteste-legemiddelmarked/ 2026-01-19T10:10:37+00:00 https://www.lmi.no/2026/01/19/norsk-gronland-toll-%e2%81%a0-det-er-en-form-for-utpressingspolitikk/ 2026-01-19T10:11:24+00:00 https://www.lmi.no/2026/01/19/snakker-ut-om-effekten-av-slankesproyter/ 2026-01-19T10:15:08+00:00 https://www.lmi.no/2026/01/19/fastlegene-gir-rad-om-vekt-samtidig-far-de-penger-fra-slankegigant/ 2026-01-19T10:16:19+00:00 https://www.lmi.no/2026/01/19/legeforeningen-forhandler-med-melanor-malet-er-full-apenhet-om-samarbeid-og-utbetalinger/ 2026-01-19T10:17:06+00:00 https://www.lmi.no/2026/01/19/ema-anbefalte-faerre-nye-legemidler-enn-fda-i-2025/ 2026-01-19T10:17:50+00:00 https://www.lmi.no/2026/01/19/domore-sjefens-frustrasjon-klinisk-studie-fem-ganger-dyrere-i-norge/ 2026-01-19T10:19:17+00:00 https://www.lmi.no/2026/01/21/inntar-forersetet-i-beslutningsforum-norge-gir-industrien-forutsigbarhet/ 2026-01-21T09:52:35+00:00 https://www.lmi.no/2026/01/21/lmi-ansetter-viseadministrerende-direktor/ 2026-01-21T09:56:26+00:00 https://www.lmi.no/2026/01/21/tezspire-fikk-ja-ganske-enkel-beslutning/ 2026-01-21T09:57:12+00:00 https://www.lmi.no/2026/01/21/13-av-14-saker-fikk-ja-i-arets-forste-beslutningsforum-kun-jaypirca-fikk-nei/ 2026-01-21T09:57:58+00:00 https://www.lmi.no/2026/01/21/als-forsker-frps-ord-har-ingen-verdi/ 2026-01-21T09:59:23+00:00 https://www.lmi.no/2026/01/21/samordner-ki-prinsipper-rettet-mot-legemiddelindustrien/ 2026-01-21T10:00:16+00:00 https://www.lmi.no/2026/01/21/debatt-nar-vi-bare-bryr-oss-om-pris-far-datakvalitet-mindre-betydning/ 2026-01-21T10:01:51+00:00 https://www.lmi.no/2026/01/21/kan-spare-opptil-16-millioner-antibiotikadoser-hvert-ar/ 2026-01-21T10:02:37+00:00 https://www.lmi.no/2026/01/21/matte-svare-for-omdiskutert-eu-direktiv-i-stortinget-jobber-for-a-ivareta-norske-interesser/ 2026-01-21T10:03:25+00:00 https://www.lmi.no/2026/01/21/arbeidet-hans-har-reddet-millioner-av-mennesker-na-er-han-bekymret-for-fremtiden/ 2026-01-21T10:04:20+00:00 https://www.lmi.no/2026/01/21/norge-godkjenner-ny-kreftbehandling-betyr-mye/ 2026-01-21T10:05:33+00:00 https://www.lmi.no/2026/01/21/keytruda-innfores-i-kurativ-behandling-av-lokalavansert-livmorhalskreft/ 2026-01-21T10:06:18+00:00 https://www.lmi.no/2026/01/21/legemiddelselskaper-vurderer-a-holde-igjen-nye-medisiner-i-europa/ 2026-01-21T10:06:57+00:00 https://www.lmi.no/2026/01/21/nykode-folger-noye-med-pa-globalt-ki-grep/ 2026-01-21T10:07:40+00:00 https://www.lmi.no/2026/01/21/marens-nyfodte-datter-fikk-rs-virus-jeg-er-fortsatt-sjokkert/ 2026-01-21T10:08:23+00:00 https://www.lmi.no/2026/01/21/legemiddelselskaper-noler-med-fdas-hurtigspor/ 2026-01-21T10:09:10+00:00 https://www.lmi.no/2026/01/21/moderna-og-msd-deler-nye-kreftvaksine-data/ 2026-01-21T10:09:53+00:00 https://www.lmi.no/2026/01/12/kommunikasjons-fagdag-med-ki-kurs/ 2026-01-21T10:13:07+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Kunstig-intelligens-KI-AI-Adobe-STock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/05/Kunstig-intelligens-KI-AI-Adobe-STock-scaled.jpeg https://www.lmi.no/2026/01/22/dette-er-de-nominerte-i-kategorien-arets-forskerinitierte-studie/ 2026-01-22T07:45:13+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde-scaled.png https://www.lmi.no/2026/01/13/dette-er-de-nominerte-i-kategorien-arets-industriinitierte-studie/ 2026-01-22T07:47:34+00:00 https://www.lmi.no/wp-content/uploads/2025/11/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/11/Kliniske-studier-prisen_ill-scaled.png https://www.lmi.no/2026/01/15/dette-er-de-nominerte-i-kategorien-arets-senter/ 2026-01-22T07:49:16+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/11/Kliniske-studier-prisen_ill-scaled.png https://www.lmi.no/2026/01/02/dette-er-de-nominerte-i-kategorien-arets-innovative-miljo/ 2026-01-22T07:50:15+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde-scaled.png https://www.lmi.no/2026/01/02/dette-er-de-nominerte-i-kategorien-arets-unge-forsker/ 2026-01-22T07:50:59+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde-scaled.png https://www.lmi.no/2026/01/19/lmi-styrker-laget-ansetter-viseadministrerende-direktor/ 2026-01-22T10:06:18+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Fredrik-w-g.png https://www.lmi.no/wp-content/uploads/2026/01/Fredrik-w-g.png https://www.lmi.no/2026/01/23/kritiserer-norge-det-er-uhyre-naivt/ 2026-01-23T10:03:45+00:00 https://www.lmi.no/2026/01/23/kronikk-usa-har-rett-om-legemiddelpriser/ 2026-01-23T10:04:44+00:00 https://www.lmi.no/2026/01/23/johnson-johnson-tror-pa-sterkere-2026-tross-prisavtale/ 2026-01-23T10:05:26+00:00 https://www.lmi.no/2026/01/23/helseberedskap-na-ma-vi-slutte-a-bullshitte-her-i-norge/ 2026-01-23T10:06:09+00:00 https://www.lmi.no/2026/01/23/kreftsjefen-pa-kalnes-subkutan-behandling-frigir-masse-tid-per-behandling/ 2026-01-23T10:06:53+00:00 https://www.lmi.no/2026/01/23/kreftsykepleier-pasientene-skal-ikke-tape-noe-pa-a-ga-over-til-subkutan-behandling/ 2026-01-23T10:07:39+00:00 https://www.lmi.no/2026/01/23/nykommerne-rykker-frem-i-brennhett-radiofarmasi-marked/ 2026-01-23T10:08:26+00:00 https://www.lmi.no/2026/01/23/kreftvaksine-gir-langvarig-effekt-ved-hoyrisiko-melanom/ 2026-01-23T10:09:11+00:00 https://www.lmi.no/2026/01/23/debatt-nar-skam-styrer-hvem-som-far-behandling/ 2026-01-23T10:10:15+00:00 https://www.lmi.no/2026/01/23/kreftforeningen-sier-klart-nei-andre-haver-inn/ 2026-01-23T10:10:55+00:00 https://www.lmi.no/2026/01/23/debatt-det-norske-systemet-skaper-forutsigbarhet-reduserer-usikkerhet-og-utviklingsrisiko/ 2026-01-23T10:12:04+00:00 https://www.lmi.no/2026/01/23/trump-hevder-a-ha-presset-macron-til-a-oke-legemiddelpriser-frankrike-benekter-pastanden/ 2026-01-23T10:12:53+00:00 https://www.lmi.no/2026/01/26/disse-kjemper-om-pris-for-fremragende-innsats-i-kliniske-studier/ 2026-01-26T11:07:31+00:00 https://www.lmi.no/2026/01/26/kreftvaksineselskap-i-krise-etter-fase-3-smell/ 2026-01-26T11:08:20+00:00 https://www.lmi.no/2026/01/26/ny-biotilsvarende-i-tnf-bio-anbudet-ekspert-tror-flere-kan-fa-biologisk-behandling/ 2026-01-26T11:09:06+00:00 https://www.lmi.no/2026/01/26/far-ikke-prove-banebrytende-medisin-%e2%81%a0-systemet-er-umenneskelig/ 2026-01-26T11:10:00+00:00 https://www.lmi.no/2026/01/26/frich-bare-16-soknader-i-tilgangsordningen-i-2025-tror-ordningen-er-for-lite-kjent/ 2026-01-26T11:10:43+00:00 https://www.lmi.no/2026/01/26/modernas-kreftvaksinedata-er-superpositive-for-nykode/ 2026-01-26T11:11:25+00:00 https://www.lmi.no/2026/01/26/endelig-program-for-beredskaps-og-helseindustrikonferansen/ 2026-01-26T11:58:18+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Design-uten-navn.jpg https://www.lmi.no/wp-content/uploads/2026/01/Design-uten-navn.jpg https://www.lmi.no/2026/01/27/dette-er-de-nominerte-i-kategorien-arets-ildsjel/ 2026-01-27T11:22:02+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Nortrials-Prisen-kl.-studier-2025-nettbilde_edited-scaled.png https://www.lmi.no/wp-content/uploads/2025/11/Kliniske-studier-prisen_ill-scaled.png https://www.lmi.no/2026/01/26/oppretter-to-nye-ekspertgrupper/ 2026-01-27T12:51:12+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2026/01/27/legemiddelindustriens-storste-oppkjop-pa-to-ar-kan-bryte-sammen/ 2026-01-27T13:10:51+00:00 https://www.lmi.no/2026/01/27/over-halvparten-fikk-nesten-klar-hud-med-ny-tyk2-tablett/ 2026-01-27T13:11:50+00:00 https://www.lmi.no/2026/01/27/who-usa-exit-gjor-verden-mindre-trygg/ 2026-01-27T13:12:39+00:00 https://www.lmi.no/2026/01/27/hs-pasienter-har-bare-en-godkjent-biologisk-medisin-eksperten-vil-ha-tilgang-pa-flere/ 2026-01-27T13:13:29+00:00 https://www.lmi.no/2026/01/28/disse-kan-vinne-kliniske-studier-pris-for-arets-senter/ 2026-01-28T09:51:59+00:00 https://www.lmi.no/2026/01/28/regjeringen-vi-inngar-ikke-en-avtale-med-usa-for-enhver-pris/ 2026-01-28T09:52:53+00:00 https://www.lmi.no/2026/01/28/million-hopp-for-denne-medisinen-ikke-losningen-for-et-vanskelig-liv/ 2026-01-28T09:53:39+00:00 https://www.lmi.no/2026/01/28/thor-medical-direktoren-radiofarmasimarkedet-blir-stort-nok/ 2026-01-28T09:54:25+00:00 https://www.lmi.no/2026/01/28/india-og-eu-har-inngatt-banebrytende-handelsavtale-senker-legemiddeltollen/ 2026-01-28T09:55:06+00:00 https://www.lmi.no/2026/01/28/exact-therapeutics-far-gront-lys-i-kreftstudie-apner-for-62-millioner-kroner/ 2026-01-28T09:55:46+00:00 https://www.lmi.no/2026/01/28/roche-med-nye-studiedata-for-fedmelegemiddel/ 2026-01-28T09:56:35+00:00 https://www.lmi.no/2026/01/28/norsk-barneleddgikt-studie-endrer-praksis-unodvendig-a-injisere-ledd-ved-oppstart-av-biologisk-behandling/ 2026-01-28T09:57:24+00:00 https://www.lmi.no/2026/01/28/slankespray-vekker-oppsikt-grovt-misvisende/ 2026-01-28T09:58:31+00:00 https://www.lmi.no/2026/01/28/priskamp-i-usa-novartis-blir-sjette-selskap-som-utfordrer-prisforhandlingene/ 2026-01-28T09:59:27+00:00 https://www.lmi.no/2026/01/29/vaksinen-rives-ut-av-apotekene-ny-forskningsrapport-far-skylden/ 2026-01-29T09:28:51+00:00 https://www.lmi.no/2026/01/29/skal-styrke-tilliten-til-beslutningsforum-ny-kommunikasjonsplan-under-arbeid/ 2026-01-29T09:29:47+00:00 https://www.lmi.no/2026/01/29/oncoinvent-utvider-jakten-pa-pasienter-fire-nye-sykehus-klare-for-fase-2-studie/ 2026-01-29T09:30:29+00:00 https://www.lmi.no/2026/01/29/disse-15-legemidlene-er-utpekt-i-usas-nye-prisgrep/ 2026-01-29T09:31:13+00:00 https://www.lmi.no/2026/01/29/storbank-astra-zeneca-vokser-raskest/ 2026-01-29T09:31:51+00:00 https://www.lmi.no/2026/01/29/har-sokt-om-utvidet-markedsforingstillatelse-for-alzheimer-behandling/ 2026-01-29T09:32:38+00:00 https://www.lmi.no/2026/01/29/dette-er-oljefondets-helseportefolje-eli-lilly-ruver-pa-topp/ 2026-01-29T09:33:19+00:00 https://www.lmi.no/2026/01/30/snurper-inn-tilgangen-pa-helvetesild-vaksine-etter-demens-oppmerksomhet/ 2026-01-30T10:07:58+00:00 https://www.lmi.no/2026/01/30/norsk-praksisendrende-blodpropp-studie-i-new-england-journal-of-medicine/ 2026-01-30T10:08:44+00:00 https://www.lmi.no/2026/01/30/salget-av-melatonin-til-himmels-ungdom-bruker-mest/ 2026-01-30T10:09:27+00:00 https://www.lmi.no/2026/01/30/debatt-kostnadskontroll-er-ikke-det-samme-som-innovasjonsbidrag/ 2026-01-30T10:12:19+00:00 https://www.lmi.no/2026/01/30/astra-zeneca-gjor-sin-storste-investering-i-kina-noensinne/ 2026-01-30T10:13:08+00:00 https://www.lmi.no/2026/01/30/fleire-et-smertestillande-blir-sa-stressa/ 2026-01-30T10:14:03+00:00 https://www.lmi.no/2026/01/30/studien-alle-vil-ha-og-forskerstjernere-disse-vant-prisene-for-kliniske-studier/ 2026-01-30T10:14:45+00:00 https://www.lmi.no/2026/01/30/legene-er-helt-uenige-hundre-prosent-ikke-innenfor/ 2026-01-30T10:18:32+00:00 https://www.lmi.no/2026/01/30/investorene-lofter-circio-henter-65-millioner-kroner-i-overtegnet-emisjon/ 2026-01-30T10:19:15+00:00 https://www.lmi.no/2026/01/30/it-krav-stopper-vurdering-av-jjs-kreftmedisin-i-norge-uheldig/ 2026-01-30T10:20:01+00:00 https://www.lmi.no/2026/01/30/feiret-kliniske-studier-delte-ut-6-priser-og-en-hederspris/ 2026-01-30T12:28:14+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Helseminister-Vestre-prisutdeling-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Helseminister-Vestre-prisutdeling-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Tore-Kvien-prisvinner-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Oslo-myelomatosesenter-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Overlord-MS-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Quintessential-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/AI-Mind-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Unge-forsker-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Ildsjel-scaled.jpg https://www.lmi.no/2026/02/02/ira-haraldsen-og-prosjektgruppen-ved-ous-er-arets-innovative-miljo/ 2026-02-02T08:39:40+00:00 https://www.lmi.no/2026/02/02/professor-tore-kvien-vant-hederspris-for-sin-innsats-innen-klinisk-forskning/ 2026-02-02T08:40:49+00:00 https://www.lmi.no/2026/02/02/ingerid-abrahamsen-og-bms-norge-vant-prisen-arets-industriinitierte-studie/ 2026-02-02T08:42:57+00:00 https://www.lmi.no/2026/02/02/kreftforsker-aslaug-helland-er-arets-ildsjel-2025/ 2026-02-02T08:45:15+00:00 https://www.lmi.no/2026/02/02/hjerteforsker-peder-langeland-myhre-er-arets-unge-forsker-2025/ 2026-02-02T08:46:03+00:00 https://www.lmi.no/2026/02/02/oslo-myelomatosesenter-er-arets-senter-2025/ 2026-02-02T08:46:49+00:00 https://www.lmi.no/2026/02/02/studien-alle-vil-ha-og-forskerstjernene-disse-vant-prisene-for-kliniske-studier/ 2026-02-02T08:47:38+00:00 https://www.lmi.no/2026/02/02/raskere-billigere-og-tettere-pa-ravarene-kina-rykker-fra-i-tidlig-legemiddelutvikling/ 2026-02-02T08:49:00+00:00 https://www.lmi.no/2026/02/02/ettersporselen-etter-vaksinen-har-okt-voldsomt-na-ma-den-rasjoneres/ 2026-02-02T08:49:55+00:00 https://www.lmi.no/2026/02/02/blodkreftforeningen-et-viktig-skritt-i-riktig-retning/ 2026-02-02T08:51:07+00:00 https://www.lmi.no/2026/02/02/ms-forsker-oivind-torkildsen-ved-haukeland-star-bak-arets-forskerinitierte-studie/ 2026-02-02T08:51:59+00:00 https://www.lmi.no/2026/02/02/astra-zeneca-inngar-ny-fedmeavtale-med-kinesisk-biotek/ 2026-02-02T09:00:12+00:00 https://www.lmi.no/2026/02/02/overlege-om-fedme-det-blir-bare-verre-og-verre/ 2026-02-02T09:01:46+00:00 https://www.lmi.no/2026/02/02/seks-legemidler-naermere-det-europeiske-markedet-etter-chmp-anbefaling/ 2026-02-02T09:02:33+00:00 https://www.lmi.no/2026/02/02/far-fedmesproyter-sendes-hjem-uten-hjelp/ 2026-02-02T09:03:30+00:00 https://www.lmi.no/2026/02/02/dmp-mottar-flere-soknader-om-kliniske-studier-glade-for-den-positive-utviklingen/ 2026-02-02T09:04:21+00:00 https://www.lmi.no/2026/02/02/comeback-for-kliniske-studier-opp-31-prosent-i-2025/ 2026-02-02T09:05:07+00:00 https://www.lmi.no/2026/02/02/lmis-generalforsamling-2/ 2026-02-02T10:14:50+00:00 https://www.lmi.no/wp-content/uploads/2022/03/Generalforsamling-2022-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/03/Generalforsamling-2022-scaled.jpg https://www.lmi.no/2026/02/02/registreringen-er-apnet-for-nordic-life-science-days/ 2026-02-02T13:28:44+00:00 https://www.lmi.no/wp-content/uploads/2026/02/NLSdays-Front-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/NLSD24-Design-2_1200x627px-1.png https://www.lmi.no/2026/02/03/oslo-science-hub-lanserer-ny-nettside/ 2026-02-03T08:32:13+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Bilde_Nettsiden_OsloScienceHub-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Bilde_Nettsiden_OsloScienceHub-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Campus_Radiumhospitalet.jpg https://www.lmi.no/2026/02/03/debatt-hvordan-gardere-seg-mot-mistanke-om-inhabilitet/ 2026-02-03T11:03:13+00:00 https://www.lmi.no/2026/02/03/utfordrer-helseministeren-om-trumps-most-favoured-nations-igjen/ 2026-02-03T11:04:06+00:00 https://www.lmi.no/2026/02/03/ny-rapport-immunterapi-under-huden-kan-halvere-kostnadene-i-sykehus/ 2026-02-03T11:05:19+00:00 https://www.lmi.no/2026/02/03/dmp-har-valgt-sin-tredje-supersatsing/ 2026-02-03T11:06:20+00:00 https://www.lmi.no/2026/02/03/takeda-norge-faller-under-milliardgrensen/ 2026-02-03T11:07:11+00:00 https://www.lmi.no/2026/02/03/gsk-om-shingrix-mangel-ettersporsel-langt-over-forventning/ 2026-02-03T11:08:32+00:00 https://www.lmi.no/2026/02/03/tid-er-den-knappeste-ressursen-i-helsetjenesten-na-ma-vi-bruke-den-bedre/ 2026-02-03T11:09:34+00:00 https://www.lmi.no/2026/02/03/de-glemte-legemidlene-har-ventet-nesten-20-ar-pa-metodevurdering-av-medisin/ 2026-02-03T11:10:23+00:00 https://www.lmi.no/2026/02/03/sanofi-og-novartis-dokumentasjon-kan-ikke-leveres-men-sakene-star-likevel-i-ventestatistikken/ 2026-02-03T11:11:16+00:00 https://www.lmi.no/2026/02/03/novo-nordisks-fedmemiddel-oppfolger-med-lovende-resultater/ 2026-02-03T11:12:05+00:00 https://www.lmi.no/2026/02/03/hedersprisen-til-tore-k-kvien-har-utgjort-en-stor-forskjell-for-kliniske-studier-i-norge/ 2026-02-03T12:03:40+00:00 https://www.lmi.no/wp-content/uploads/2026/01/Tore-Kvien-prisvinner-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Tore-Kvien-prisvinner-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/01/Tore-Kvien-prisvinner-1-scaled.jpg https://www.lmi.no/2026/02/03/til-minne-om-felleskatalogens-far-holger-moe-torisen-1941-2026/ 2026-02-03T13:06:44+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Holger-og-kongen-redigert-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Holger-Moe-Torisen-hos-kongen_FOTOScanpix-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Holger-Moe-Torisen-scaled.jpeg https://www.lmi.no/2026/01/21/fortsatt-mulig-a-bli-lmi-partner-under-arendalsuka/ 2026-02-05T09:53:23+00:00 https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-23-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-23-scaled.jpg https://www.lmi.no/2026/02/05/vurderer-a-stoppe-karo-healthcares-oppkjop-av-aco-hud-nordic/ 2026-02-05T10:17:31+00:00 https://www.lmi.no/2026/02/05/brutalt-kursfall-i-novo-nordisk-aksjonaerverdier-for-285-mrd-danske-kroner-barbert-vekk/ 2026-02-05T10:20:03+00:00 https://www.lmi.no/2026/02/05/mange-synes-det-er-sa-vondt-a-miste-haret-at-de-isolerer-seg/ 2026-02-05T10:21:19+00:00 https://www.lmi.no/2026/02/05/salget-av-legemidler-pa-resept-har-okt-30-prosent-pa-ti-ar/ 2026-02-05T10:23:31+00:00 https://www.lmi.no/2026/02/05/kreftsyke-geir-har-fatt-gode-nyheter-na-er-det-lov-a-hape-at-dette-gar-veien/ 2026-02-05T10:29:24+00:00 https://www.lmi.no/2026/02/05/gladnyhet-til-norske-kreftpasienter-det-vil-ha-stor-betydning/ 2026-02-05T10:33:15+00:00 https://www.lmi.no/2026/02/05/over-800-nordmenn-dor-arlig-av-krefttypen-forskere-med-gjennombrudd/ 2026-02-05T10:35:56+00:00 https://www.lmi.no/2026/02/05/pa-europa-tokt-%e2%81%a0-vi-er-sarbare-uten-eu/ 2026-02-05T10:38:39+00:00 https://www.lmi.no/2026/02/05/boehringer-ingelheim-norge-henter-myndighetskontakt-fra-eli-lilly/ 2026-02-05T10:40:07+00:00 https://www.lmi.no/2026/02/05/fiskehelse-her-har-bransjen-endra-seg-fullstendig-pa-disse-ti-ara/ 2026-02-05T10:42:43+00:00 https://www.lmi.no/2026/02/05/68542/ 2026-02-05T10:42:51+00:00 https://www.lmi.no/wp-content/uploads/2026/02/tall.png https://www.lmi.no/2026/02/05/hoyre-flere-overlever-men-hjelpen-gar-tregere/ 2026-02-05T10:44:41+00:00 https://www.lmi.no/2026/02/05/legemiddelfabrikken-er-en-motor-for-store-deler-av-det-lokale-naeringslivet/ 2026-02-05T10:53:04+00:00 https://www.lmi.no/2026/02/05/fakta-om-norges-mest-solgte-legemidler/ 2026-02-05T10:55:04+00:00 https://www.lmi.no/2026/02/05/norsk-oppdrettslaks-dodelegheita-under-15-prosent-for-forste-gong-pa-fleire-ar/ 2026-02-05T10:56:09+00:00 https://www.lmi.no/2026/02/05/klima-og-miljoministeren-har-svart-sp-om-avlopsdirektivet/ 2026-02-06T07:10:46+00:00 https://www.lmi.no/wp-content/uploads/2025/12/Urban-waste-water-treatment_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/12/Urban-waste-water-treatment_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2026/02/Klima-og-miljominister-Eriksen.jpg https://www.lmi.no/2026/02/06/bms-norge-sjefen-diskusjonene-om-kliniske-studier-tas-i-okende-grad-i-norden/ 2026-02-06T08:52:59+00:00 https://www.lmi.no/2026/02/06/helseministeren-bekymret-for-utviklingen-i-usa-ser-mer-til-europa/ 2026-02-06T08:54:41+00:00 https://www.lmi.no/2026/02/06/novo-nordisk-varsler-grep-mot-billig-pille/ 2026-02-06T08:55:58+00:00 https://www.lmi.no/2026/02/06/kommentar-beslutningsforum-har-ikke-et-kommunikasjonsproblem-det-har-politikerne/ 2026-02-06T08:57:29+00:00 https://www.lmi.no/2026/02/06/fann-banebrytande-metode-for-a-avdekke-aggressiv-kreftform/ 2026-02-06T08:58:19+00:00 https://www.lmi.no/2026/02/06/ge-healthcare-skyter-inn-33-millioner-kroner-i-exact-therapeutics/ 2026-02-06T08:59:25+00:00 https://www.lmi.no/2026/02/06/salgsfest-for-eli-lilly-leverer-over-forventning/ 2026-02-06T09:00:21+00:00 https://www.lmi.no/2026/02/06/disse-ti-legemidlene-ventes-a-dominere-markedet-frem-mot-2032/ 2026-02-06T09:01:19+00:00 https://www.lmi.no/2026/02/06/for-forste-gang-car-t-konkurranse-i-norge/ 2026-02-06T09:02:23+00:00 https://www.lmi.no/2026/02/09/omstridte-kopimedisiner-usa-myndighet-varsler-grep/ 2026-02-09T08:27:07+00:00 https://www.lmi.no/2026/02/09/beslutningsforum-skal-ta-stilling-til-celleterapi-og-subkutan-keytruda/ 2026-02-09T08:28:16+00:00 https://www.lmi.no/2026/02/09/bruken-oker-blant-unge-kvinner-ingen-mirakelpille-mot-angst/ 2026-02-09T08:30:24+00:00 https://www.lmi.no/2026/02/09/trump-lanserer-trumprx-vil-presse-legemiddelprisene-ned/ 2026-02-09T08:31:16+00:00 https://www.lmi.no/2026/02/09/ge-healthcare-rigger-om-for-a-unnga-tollsmell/ 2026-02-09T08:32:12+00:00 https://www.lmi.no/2026/02/09/dette-skjer-i-uke-7-helsevedtak-i-stortinget-kan-overkjore-regjeringens-politikk/ 2026-02-09T08:33:14+00:00 https://www.lmi.no/2026/02/09/big-pharma-topper-samles-i-oslo-unikt/ 2026-02-09T08:33:59+00:00 https://www.lmi.no/2026/02/09/toppmote-bak-lukkede-dorer-om-legemiddelpriser-uten-regjeringen-til-stede/ 2026-02-09T08:35:40+00:00 https://www.lmi.no/2026/02/09/nye-ansikter-i-roche-norge/ 2026-02-09T08:37:53+00:00 https://www.lmi.no/2026/02/09/debatt-et-prioriteringssystem-som-ikke-forstar-hjernesykdommer/ 2026-02-09T08:39:57+00:00 https://www.lmi.no/2026/02/09/debatt-nar-dokumentert-behandling-ikke-nar-pasientene/ 2026-02-09T08:41:16+00:00 https://www.lmi.no/2026/02/09/medlemsmote-oppdatering-fra-lmis-komiteer/ 2026-02-09T09:10:34+00:00 https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/2026/02/09/ous-med-nye-regler-for-industrisamarbeid-ma-ha-et-system-som-forhindrer-bindinger/ 2026-02-09T10:01:07+00:00 https://www.lmi.no/2026/02/09/tok-med-medlemsselskaper-til-washington/ 2026-02-09T11:03:02+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Image-1-edited.jpg https://www.lmi.no/wp-content/uploads/2026/02/Image-1-edited.jpg https://www.lmi.no/2026/02/09/frokostmote-slik-jobber-dnv-med-helsedata/ 2026-02-09T15:00:54+00:00 https://www.lmi.no/wp-content/uploads/2026/02/DNV_AdobeStock_Kun-redaksjonell-bruk-scaled.jpeg https://www.lmi.no/wp-content/uploads/2026/02/DNV_AdobeStock_Kun-redaksjonell-bruk-scaled.jpeg https://www.lmi.no/2026/02/04/workshop-om-hvordan-norge-skal-tiltrekke-studier-innen-radiofarmasi/ 2026-02-09T15:24:55+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Monica-workshop-radiofarmasi-scaled.jpeg https://www.lmi.no/wp-content/uploads/2026/02/Workshop-radiofarmasi-scaled.jpeg https://www.lmi.no/wp-content/uploads/2026/02/Monica-workshop-radiofarmasi-scaled.jpeg https://www.lmi.no/2026/02/10/her-far-anne-karin-74-vaksinen-som-kan-forebygge-demens-var-ikkje-eit-sporsmal/ 2026-02-10T08:52:09+00:00 https://www.lmi.no/2026/02/10/beslutningsforum-sa-nei-til-behandling-for-kronisk-hudsykdom-dette-er-trist/ 2026-02-10T08:54:14+00:00 https://www.lmi.no/2026/02/10/sa-nei-til-flere-nye-legemidler-prisen-er-rett-og-slett-for-hoy/ 2026-02-10T08:55:03+00:00 https://www.lmi.no/2026/02/10/innforer-msds-subkutane-keytruda-i-norge/ 2026-02-10T08:55:46+00:00 https://www.lmi.no/2026/02/10/amgen-norge-dmp-skyver-problemet-foran-seg/ 2026-02-10T08:59:14+00:00 https://www.lmi.no/2026/02/10/bms-slar-forventningene-tross-patentpress/ 2026-02-10T09:00:18+00:00 https://www.lmi.no/2026/02/10/historisk-partnerskap-skal-gi-et-loft-for-kliniske-studier/ 2026-02-10T09:01:09+00:00 https://www.lmi.no/2026/02/10/nytt-strategisk-partnerskap-skal-styrke-helse-og-livsvitenskap-i-norge/ 2026-02-10T09:21:04+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Guro-Bjontegaard-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Guro-Bjontegaard-scaled.jpg https://www.lmi.no/2026/02/09/arrangerte-high-level-meeting-om-mfn/ 2026-02-10T13:04:53+00:00 https://www.lmi.no/wp-content/uploads/2026/02/High-level-meeting-MFN-09022026.jpg https://www.lmi.no/wp-content/uploads/2026/02/High-level-meeting-MFN-09022026.jpg https://www.lmi.no/2026/02/10/de-nye-komiteene-er-i-gang/ 2026-02-10T21:04:14+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Industry-Development-Committee-2026.jpg https://www.lmi.no/wp-content/uploads/2026/02/Industry-Development-Committee-2026.jpg https://www.lmi.no/2026/02/11/debatt-vi-kan-ikke-importere-oss-ut-av-neste-krise/ 2026-02-11T07:50:42+00:00 https://www.lmi.no/2026/02/11/amerikanske-eksperter-slik-blir-forskning-investerbar-og-derfor-feiler-sa-mange-life-science-prosjekter/ 2026-02-11T07:51:43+00:00 https://www.lmi.no/2026/02/11/milliardavtale-om-kreft-og-immunologi-mellom-eli-lilly-og-innovent-biologics/ 2026-02-11T07:52:38+00:00 https://www.lmi.no/2026/02/11/kronikk-norge-vil-lope-i-front-men-ikke-ta-regningen-for-framtidens-medisiner/ 2026-02-11T07:53:44+00:00 https://www.lmi.no/2026/02/11/har-tro-pa-norsk-helsesatsing/ 2026-02-11T07:55:58+00:00 https://www.lmi.no/2026/02/11/astra-zeneca-kopierer-svensk-suksessmodell-i-norge/ 2026-02-11T07:56:51+00:00 https://www.lmi.no/2026/02/11/ous-strammer-inn-og-formaliserer-samarbeid-med-industrien/ 2026-02-11T07:58:16+00:00 https://www.lmi.no/2026/02/11/nar-skal-kreft-behandles-darzalex-vurderes-for-myelomatose-blir-aktiv/ 2026-02-11T07:59:08+00:00 https://www.lmi.no/2026/02/11/bayer-topp-med-klar-beskjed-til-norge-forskere-misliker-byrakrati-investorer-hater-det/ 2026-02-11T07:59:56+00:00 https://www.lmi.no/2026/02/11/fokus-slar-storrelse-ge-healthcares-globale-forskningssjefs-rad-til-norsk-life-science/ 2026-02-11T08:01:02+00:00 https://www.lmi.no/2026/02/11/debatt-i-medwatch-vi-kan-ikke-importere-oss-ut-av-neste-krise/ 2026-02-11T09:58:28+00:00 https://www.lmi.no/wp-content/uploads/2026/02/MedWatch100226.png https://www.lmi.no/wp-content/uploads/2026/02/MedWatch100226.png https://www.lmi.no/2026/02/11/norway-life-science-2026-sma-alene-sterkere-sammen/ 2026-02-11T12:08:44+00:00 https://www.lmi.no/wp-content/uploads/2026/02/kGQc7wrg.jpeg https://www.lmi.no/wp-content/uploads/2026/02/kGQc7wrg.jpeg https://www.lmi.no/2026/02/10/norway-life-science-2026-globale-selskap-har-tro-pa-norge/ 2026-02-11T12:09:48+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Norway-Life-Science-2026_Bayer-og-GE-HealthCare-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Norway-Life-Science-2026_Bayer-og-GE-HealthCare-scaled.jpg https://www.lmi.no/2026/02/12/pharma-toppene-advarer-uten-raskere-tilgang-og-mindre-byrakrati-flytter-innovasjonen/ 2026-02-12T09:35:08+00:00 https://www.lmi.no/2026/02/12/kronikk-er-legemiddelindustrien-en-bransje-som-roper-ulv/ 2026-02-12T09:36:15+00:00 https://www.lmi.no/2026/02/12/undersokelse-viser-flere-barrierer-for-bruk-av-tilgangsordningen/ 2026-02-12T09:36:57+00:00 https://www.lmi.no/2026/02/12/legemiddeltoppenes-advarsel-nye-usa-regler-kan-fore-til-anbudsnekt-i-europa/ 2026-02-12T09:37:41+00:00 https://www.lmi.no/2026/02/11/norway-life-science-2026-pharmaq-om-vaksinenes-betydning/ 2026-02-12T09:48:26+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Pharmaq-Norway-Life-Science-2026-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Pharmaq-Norway-Life-Science-2026-1-scaled.jpg https://www.lmi.no/2026/02/10/norway-life-science-2026-globale-endringer-utfordrer-modellen-for-legemiddelinnovasjon/ 2026-02-12T09:49:08+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Norway-Life-Science-2026_Innovation-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Norway-Life-Science-2026_Innovation-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Norway-Life-Science_FireSide-chat-scaled.jpg https://www.lmi.no/2026/02/12/norway-life-science-2026-helsedata-ma-bli-integrert-del-av-behandlingen-og-deles-mer-med-industrien/ 2026-02-13T08:44:46+00:00 https://www.lmi.no/wp-content/uploads/2026/02/Helsedata_panelsamtale_NLS2026-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Helsedata_panelsamtale_NLS2026-scaled.jpg https://www.lmi.no/wp-content/uploads/2026/02/Helsedata_publikum_NLS2026-scaled.jpg https://www.lmi.no/2026/02/13/debatt-vi-ma-se-hvilken-verdi-investeringer-gir-utenfor-helsetjenestens-fire-vegger/ 2026-02-13T13:24:24+00:00 https://www.lmi.no/2026/02/13/tidsbruken-i-nye-metoder-gar-ned-disse-tiltakene-er-innfort/ 2026-02-13T13:25:38+00:00 https://www.lmi.no/2026/02/13/cdmo-kunder-lofter-arcticzymes-salget/ 2026-02-13T13:26:46+00:00 https://www.lmi.no/2026/02/13/kaster-toppsjefen-i-sanofi/ 2026-02-13T13:30:30+00:00 https://www.lmi.no/2026/02/13/debatt-vaksine-legemiddel-eller-folkehelsetiltak-i-metodevurdering/ 2026-02-13T13:31:55+00:00 https://www.lmi.no/2026/02/13/antibiotika-lofter-navamedic-tross-fall-i-fedmelegemiddelsalget/ 2026-02-13T13:32:37+00:00 https://www.lmi.no/2026/02/13/pfizer-ber-stortinget-gripe-inn-i-terskelverdi-striden/ 2026-02-13T13:33:20+00:00